Een recent wetenschappelijk overzicht van planten die tegen kanker gebruikt worden
Allium sativum: It is used for the treatment of cardiovascular atherosclerosis, HIV drug-induced lipid disorders, cancer prevention, colds and the flu, and tick bite prevention [14,15]. It seems to be active against erythroleukemia as well as breast and prostate cancer cells [16,17].
Amorphophallus konjac: Used in reduction of serum cholesterol and in constipation, control of blood glucose . Luo  found that glucomannan protected mice against clinically induced lung cancer.
Annona triloba: Acetogenins of this herb have been found to be active aginst certain lung and breast cancers . This herb is also used to treat fever, vomiting, and oral inflammation .
Arachis hypogaea: It is used to lower cholesterol, aid in weight loss, or prevent cardiovascular conditions and cancer [22, 23].
Aronia melanocarpa: Aronia melanocarpa has a high concentration of polyphenols and anthocyanins, stimulating circulation, protecting the urinary tract, and strengthening the heart. Its rich antioxidant content may be beneficial as a dietary preventative for reducing the risk of diseases caused by oxidative stress. Several investigators reported to treat conditions such as colorectal cancer , colon cancer , cardiovascular disease  chronic inflammation , gastric mucosal disorders [peptic ulcer] , eye inflammation [uveitis]  and liver failure .
Asparagus officinalis: Leung and Foster,  reported that this possess cancer preventing property. It also has a role in controlling urinary tract infections .
Asparagus racemosus: It is useful in treating tumours, nervous disorders, dyspepsia, tuberculosis, cough, bronchitis, gleet, gonorrhoea, leucorrhoea, leprosy, epilepsy, fatigue, hyperacidity, colic haemorrhoids, hypertension, abortion, cardiac and general debility .
Astragalus gummifera: It inhibits cancer cell growth  and used in treating the carcinogenesis.
Bacopa monniera: The plant is anticancerous and improves learning ability. The plant is astringent, bitter, sweet, cooling, laxative, intellect promoting, anodyne, carminative, digestive, antiinflammatory, anticonvulsant, depurative, cardiotonic, bronchodialator, diuretic, emmenagogue, sudorfic, febrifuge and tonic .
Bleekeria vitensis: Widely used in Europe in the treatment of advanced breast cancer . Elliptinium, a derivative of ellipticine, isolated from a medicinal plant Bleekeria vitensis A.C. Sm., is marketed in France for the treatment of breast cancer .
Brassica oleracea: Used for gastrointestinal disorders, asthma, morning sickness, and preventing osteoporosis, individuals also use it to prevent lung, stomach, colorectal, breast, and other cancers  Several studies reported that this may have anticarcinogenic properties [36-38].
Camellia sinensis: Used to prevent prostate, colon, and gastric cancers [39-40]. It is also used to prevent skin cancer or damage from ultraviolet radiation . It seems to reduce the risk of some cancers by preventing blood vessel growth in tumors 
Carmona retusa: Commonly used as tea or tonic drink to treat stomach ailments and popular as antibacterial and have a high potential infighting the growth and multiplication of cancer cells .
Catharanthus roseus: It is one of the very few medicinal plants, which has a long history of uses as diuretic, antidysenteric, haemorrhagic and antiseptic. It is known for use in the treatment of diabetes in Jamaica and India. The alkaloids vinblastine and vincristine present in the leaves are recognized as anticancerous drugs. Vinblastine is used in combination with other anticancer agents for the treatment of lymphocytic lymphoma, Hodgkin’s disease - cancer affecting lymph glands, spleen and liver, testicular carcinoma and choriocarcinoma. Vincristine is used in acute leukemia, lymphosarcoma and Wilm’s tumour . Vinblastine and vincristine are primarily used in combination with other cancer chemotherapeutic drugs for the treatment of a variety of cancers, including leukemias, lymphomas, advanced testicular cancer, breast and lung cancers, and Kaposi’s sarcoma .
Chrysanthemum morifolum: This may reverse precancerous gastrointestinal lesions .
Coleus forskholii: It is useful in the treatment of cancer, congestive heart failure [46-47]. The active principle of Coleus forskohlii, forskolin, increase of cyclic AMP levels in the culture medium of human prostatic cancer cells thereby cellular growth of the cancer found inhibited. This will be a possible new, safe approach to prostatic carcinoma therapy .
Combretum caffrum: The bark of the Combretum caffrum is combined with a number of other herbs, together they form a formidable anti-cancer treatment. Varieties of anti-cancer compounds called combretastatins are found within the tree bark of Combretum caffrum the most potent of which is combretastatin CA-4. Combretastatins bind to the protein tubulin, which is essential to cytoskeletal architecture, intercellular transport, cell migration, wound healing, and mitotic spindle development for chromosome segregation and cell division. A member of the mitotic inhibitor class of anti-cancer drugs, combretastatin disrupts tumor blood vessel networks by constricting blood supply to tumours. Combretastatin A-4 is active against colon, lung and leukemia cancers and it is expected that this molecule is the most cytotoxic phytomolecule isolated so far [48,49].
Crocus sativus: It helps in increasing white blood cell count and disinfects secretions, including mucus, sweat and urination. It also increases appetite, clears the lungs, and helps heal the skin and mucous membranes. It is commonly used for cough and cold, decreased appetite and general weakness and also in the treating cancer .
Curcuma longa: Used to manage gastrointestinal discomfort and colorectal cancer . This herb may have bile-stimulating, liver-protectant, antioxidant, and anticancer effects .
Daphne genkwa: The flower buds are used to control coughs. The buds are anticoagulant, antiseptic, antitussive, antiviral, diuretic, purgative and stomachic [51,52]. They are used internally in the treatment of bronchitis, constipation, oedema and skin diseases . Kai et al.,  reported antitumour, antiallergy and antiinflammatory activities.
Datura metal: The plant or the different alkaloids have anticancerous, antitumour activities and it has narcotic, anthelmintic, spasmolytic anaesthetic, sedative, ophthalmic, antirheumatic, antiasthmatic, antidiarrhoeal and anticatarrhal activities . Leaf is antitumour, antirheumatic and vermicide. Flower is antiasthamatic, anaesthetic and is employed in swellings and eruptions on face. Fruit juice is used in earache and seed decoction in ophthalmia. The alkaloids of pharmaceutical interest present in the plant are hyoscyamine, hyoscine and meteloidine.
Dysoxylum binectariferum: Ayurvedic plant, used for rheumatoid arthritis. Rohitukine was isolated as the constituent responsible for anti-inflammatory and immunomodulatory activity Flavopridol, was found to possess tyrosine kinase activity and potent growth inhibitory activity against a series of breast and lung carcinoma cell lines. It also showed broad spectrum in vivo activity against human tumor xenografts in mice, either alone or in combination with other anti-cancer agents, against a broad range of tumors, including leukemias, lymphomas and solid tumors .
Ginko biloba: Used to treat conditions like altitude sick ness, asthma, depression, disorientation, headaches, high blood pressure, erectile dysfunction and vertigo. It has found to improve thinking, learning and memory in people with Alzheimers disease (AD). This herb also improves blood flow. Suzuki et al.,  reported that extract of leaves has anti cancer activity.
Gloriosa superba: The roots and rhizomes are used in traditional system of medicine. Rhizome is anticancerous, oxytocic, antimalarial, stomachic, purgative, cholagogue, anthelmintic, alterative, febrifuge and antileprotic. Leaf is antiasthmatic and antiinflammatory. Root shows antigonorrhoeic and antibiotic activity .
Glycine max: The protective action of this plant on breast cancer was experimentally demonstrated by [58-60].
Gynostemma pentaphyllum: Used to treat cancer, cardiovascular and gastrointestinal disorders, diabetes, and obesity, and for strengthening the immune system. It is also used as an anti-inflammatory agent, antioxidant, or detoxifying agent .
Hibiscus sabdariffa: It is a medicinal herb, used in folk medicine in treatment of hypertension . Hibiscus anthocyanins, a group of phenolic natural pigments present in the dried flower of Hibiscus sabdariffa, have been found to have cardioprotective , hypocholesterolemic , anti-oxidative and hepatoprotective  effects in animals. Hibiscus sabdariffa flowers stimulate proliferation and differentiation of human keratinocytes . Hibiscus protocatechuic acid has inhibitory and inductive effect on tumour promotion in mouse skin and in human leukemia cells respectively . Hibiscus sabdariffa has been reported to be antiseptic, aphrodisiac, astringent, cholagogue, demulcent, digestive, diuretic, emollient, purgative, refrigerant, sedative, stomachic and tonic .
Kaempferia rotunda: The tubers of Indian crocus are widely used as a local application for tumours, swellings and wounds. The tubers are antitumour, antiinflammatory, sialagogue, emetic, and vulnerary. It also improves complexion and cures burning sensation [66,67].
Lagerstroemia speciosa: It is popular in treating kidney troubles and serves as an anti-diuretic and its bark extract is efficient to counter cancer cells .
Larrea divaricata: Used to treat cancer, tuberculosis, and venereal disease . It also has the potential for anticarcinogenic and antimutagenic activity .
Lavandula angustifolia: This plant can be used to prevent multiplication of cancer cells. In vitro and animal studies have shown anticancer activity of L. angustifolia .
Momordica charantia: It has antimicrobial , antiviral (anti HIV)  antitumour  and antimutagenic  effects. In Mexico, the entire plant is used for dysentery; the root is a reputed aphrodisiac. In Peruvian herbal medicine, the leaf or aerial parts of the plant are used to treat measles, and all types of inflammation. In Nicaragua, the leaf is commonly used for stomach pain, fevers, colds, coughs, headaches, skin complaints, menstrual disorders, aches and pains, hypertension, infections, and as an aid in childbirth.
Nigella sativa: Used in self-medication for gastrointestinal conditions and as an im-munoprotectant against cancer . Some of the studies reported that it is an anticancer agent, inhibiting stomach tumors, carcinoma, and Ehrlich ascites carcinoma [75,76].
Olea europaea: Used to treat breast cancer , others take it to prevent colorectal cancer and in cardiovascular complications .
Oryza sativa: Used in the treatment of diabetes and hypertension, cardiovascular disease  and bowel cancer .
Oxcycocus macrocarpos: It is used to treat or prevent cancer [22, 79-80]. Plant juice and products can reduce the number of breast cancer tumors, delay tumor development, and slow metastases of cancer to lungs and lymph nodes 
Plantago ovata: Used to treat hypercholesterolemia, hyperglycemia, and cancer . Gerber,  reported that it decrease absorption of carcinogens and unconjugated estrogens.
Podophyllum peltatum: The plant has podophyllotoxin, can be used as cytostastic  and topically in the treatment of genital warts . The plant has been used especially in the treatment of ovarian cancer . Epipodophyllotoxin is an isomer of podophyllotoxin which was isolated as the active antitumor agent from the roots of Podophyllum species, Podophyllum peltatum Linn. .
Polygonum tinctorium: Their use increases the phagocytosis of white blood cells and decreases the permeability of the capillaries. The leaves and fruits are used to protect and the prevention of leukemia [51-52]. Koya et al.,  reported anticancer activity.
Raphanus sativus: The plant shows anti tumour activity. The leaves, seeds and old roots are used in the treatment of asthma and other chest complaints . Synthetic agent roscovitine, an anticancer drug which is derived from natural product olomucine, originally isolated from Raphanus sativus L., is in Phase II clinical trials in Europe [35, 87].
Rhus succedanea: The fruit is used in the treatment of phthisis . A wax from the fruits is used in ointments. An ethanolic extract of the leaves exhibits anticancer and antiviral activities . Ethanolic extract of sap also has anticancer activity .
Spinacia oleracea: Used to treat gastrointestinal complaints and fatigue, induce blood building, and stimulate the appetite  and prevent cancer 
Taxus brevifolia: It contains the substance ‘taxol’ in its shoot and bark. Taxol has shown exciting potential as an anticancer drug, particularly in the treatment of ovarian cancer . All parts of the plant, except the fleshy fruit, are diaphoretic and pectoral. A decoction of the branches and leaves has been used in the treatment of lung cancer .
Tebebuia impetiginosa: This plant improves quality of life for cancer and immunodepressed patients. However, the main active compound lapachol has since turned out to be toxic enough to kill a human imbibing the quantities required for a therapeutic effect on those diseases. Lapachol has strong antibiotic and disinfectant properties, and may be better suited for topical applications. Species of the genus Tabebuia sps. have a history of use in the treatment of several diseases, including syphilis, fevers, malaria, cutaneous infections, stomach disorders and significant activity against a range of tumor cell lines, including breast, leukemia and prostate lines .
Terminalia paniculata: The stem bark is anticancerous, diuretic, cardiotonic CVS active and shows antagonism of amphetamine hyperactivity. Flower is anticholerin .
Triticum aestivum: Used to prevent colon cancer and other colon conditions [93-95]. It is also used in the prevention of breast cancer .
Vaccinium angustifolium: Used in the treatment for ulcers, urinary tract infections, multiple sclerosis, varicose veins, hemorrhoids [97-98]. The antioxidant effects of blueberry extracts may have anticancer activities, according to preliminary research .
Vaccinium myrtillus: This contains dense levels of anthocyanin pigments linked experimentally to lowered risk for several diseases, such as those of heart, eye and cardiovascular system and cancer [26, 99-101].
Viscum album: It has been employed in checking internal haemorrhages, in treating cancer of the stomach, lungs and ovaries . The plant has also been used to treat arthritis, rheumatism, chilblains, leg ulcers and varicose veins, epilepsy and other convulsive nervous disorders. Cazacu et al.,  reported anticancer activity in vitro and in vivo.
Vitex negundo: Used to treat chronic bronchitis. They are useful in dispersing swellings of the joints from acute rheumatism, and of the testes from suppressed gonorrhoea. The juice of the leaves is used for removing foetid discharges and worms from ulcers, while oil prepared with the leaf juice is applied to sinuses and scrofulous sores. A decoction of the stems is used in the treatment of burns and scalds . Extracts of the leaves have shown bactericidal and antitumor  and cytotoxic activity aginst cancer cell lines .
Yucca glauca: Yucca is used to treat arthritis, hypertension, headaches, diabetes, and gastrointestinal conditions [31,68]. It exhibit antitumor activity against B16 melanoma but not against L1210 and P388 leukemias in mice [18, 31, 68, 93].
Herbs are staging a comeback and herbal ‘renaissance’ is occurring all over the globe. The herbal products today symbolise safety in contrast to the synthetics that are regarded as unsafe to human and environment. Although herbs had been priced for their medicinal, flavouring and aromatic qualities for centuries, the synthetic products of the modern age surpassed their importance, for a while. However, the blind dependence on synthetics is over and people are returning to the naturals with hope of safety and security. Green plants synthesise and preserve a variety of bioactive compounds, many of which are extractable and used as chemical feedstocks or as raw material for various scientific investigations.
Many secondary metabolites of plant are commercially important and find use in a number of pharmaceutical compounds. Over three-quarters of the world population relies mainly on plants and plant extracts for health care. It is estimated that world market for plant derived drugs may account for about Rs.2, 00,000 crores. The annual production of medicinal and aromatic plant’s raw material is worth about Rs.200 crores. This is likely to touch and US $5 trillion by 2050. It has been estimated that in developed countries such as United States, plant drugs constitute as much as 25% of the total drugs, while in fast developing countries such as China and India contribution is as much as 80% . Thus, the economic importance of medicinal plants is much more to countries such as India than to rest of the world. These countries provide two third of the plants used in modern system of medicine and the health care system of rural population depend on indigenous systems of medicine.
Not only, that plant-derived drug offers a stable market world wide, but also plants continue to be an important source for new drugs. Natural products discovered from medicinal plants have played an important role in the treatment of cancer. Natural products or natural product derivatives comprised 14 of the top 35 dugs in 2000 based on world sales . Two plant derived natural products, paclitaxol and camptothecin were estimated to account for nearly one- third of the global anticancer market or about $3 billion of $9 billion in total annually in 2002 . Of the 2,50,000 higher plant species on earth, more than 80,000 are medicinal. India is net of the world’s 12 biodiversity centres with the presence of over 45000 different plant species. India’s diversity is unmatched due to the presence of 16 different agro-climatic zones, 10 vegetation zones, 25 biotic provinces and 426 biomes [habitats of specific species]. Of these, about 15000-20000 plants have good medicinal value.
However, 7000-7500 species has been explored for their medicinal values. India also inherited the long lasting system of medicinal ‘Ayurveda’ where plant products are utilized as remedies for various disorders. These health care measures are also to be enriched and conserved. It should be taken care, some of the herbs are deadly poisonous and some are extremely dangerous. So, the scientific study on derivation of drugs through bioprospecting and systematic conservation of the concerned medicinal plants are thus of great importance.
1. Dalziel T.M. The Useful Plants of West Tropical Africa. 3rd ed. Bradford and London: Watmought Ltd., Idle; 1973. p.526-530
2. Parkin D.M., Bray F., Ferlay J., Pisani P. Global cancer statistics, 2002. CA Cancer J. Clin. 2005; 55(2): 74-108.
3. Hoyer D.L., Kung H.C., Smith B.L. Natl Vital Stat Rep. 2005; 53: 1-48.
4. Samuelsson G. Drugs of Natural Origin: A Textbook of Pharmacognosy. 4th ed. Stockholm: Swedish Pharmaceutical Press; 1999. p.97.
5. Cragg G.M., Newman D.J., Sander K.M. Natural products in drug discovery and development. J. Nat. Prod. 1997; 60(1): 52-60.
6. Kappor L.D. CRC Handbook of Ayurvedic Medicinal Plants. Boca Raton, Florida: CRC Press; 1990. p.416-417.
7. Joy P.P., Thomas J., Mathew S., Jose G., Joseph J. Medicinal plants. In: Bose T.K., Kabir J., Das P., Joy P.P. editors. Tropical Horticulture Vol. 2. Calcutta: Naya Prokash.; 2001. p.449-632.
8. Hernandez E.G., Contreras A.A., Santamaria A., Ramos R.R., Miranda A.A.C., Vega L.M.G., Saenz J.L.F., Aguilar F.J.A. Studies on Hypoglycemic Activity of Mexican Medicinal Plants. Proc. West Pharmacol. Soc. 2002; 45: 118-124.
9. Bauer B.A. Herbal therapy: what a clinician needs to know to counsel patients effectively? Mayo Clin. Proc. 2000; 75(8): 835-841.
10. P.L.M . Diccionario de especialidades farmacéuticas. México, D.F; 2003.
11. DanielFabricant S., Farnsworth N.R. The value of plants used in traditional medicine for drug discovery. Environmental Health Perspectives. 2002; 109(1): 69-75.
12. Shoeb M. Cytotoxic compounds from the Genus Centaurea. PhD Thesis. Aberdeen, UK, The Robert Gordon University; 2005.
13. Jaspars M., Lawton L.A. Cyanobacteria as a novel source of pharmaceuticals. Curr. Opin. Drug Discovery Develop. 1998; 1(1): 77-84.
14. Bloch A.S. Pushing the envelope of nutrition support: complementary therapies. Nutrition. 2000; 16(3): 236-239.
15. Micromedex® Healthcare Series, (electronic version). Thomson Micromedex, Greenwood Village, Colorado, USA. Available at: http://0-www.thomsonhc.com.library.uchsc.edu:80; 2004.
16. Sigounas G., Hooker J., Angnostou A., Steiner M. S-allyl-mercaptocysteine inhibits cell proliferation and reduces the viability of erythroleukemia, breast, and prostate cancer cell lines. Nutrition and Cancer. 1997; 27: 186-191.
17. Zhang Y., Moriguchi T., Saito H., Nishiyama N. Functional relationship between age-related immunodeficiency and learning deterioration. New Eur. J. Neurosci.1998; 10: 3869-3875.
18. Facts and Comparisons. The Lawrence Review of Natural Products–Monograph System. St. Louis, MO: Wolter Kluwer; 2001. p.41.
19. Luo D.Y. Inhibitory effect of refined Amorphophallus konjac on MNNG-induced lung cancer in mice. Zhonghua Zhong Liu Za Zhi. 1992; 14(1): 48-50.
20. He K., Zhao G.X., Shi G., Zeng L., Chao J.F., McLaughlin J.L. Additional bioactive annonaceous acetogenins from Asminia triloba (Annonaceae). Bioorganic and Medicinal Chemistry. 1997; 5(3): 501-506.
21. Gruenwald J., Brendler T., Jaenicke C. PDR for Herbal Medicines. 1st ed. Montvale, NJ: Medical Economics Co. Inc..; 1998. p.179-180.
22. Natural Medicines Comprehensive Database. Therapeutic Research National Faculty Database. Available at http:/www.naturaldatabase.com
23. La Vecchia C., Negri E., Franceschi S., Decarli A., Giacosa A., Lipworth L. Olive oil, other dietary fats, and the risk of breast cancer. Cancer Causes Control. 1995; 6(6): 545–550.
24. Lala G., Malik M., Zhao C., He J., Kwon Y., Giusti M.M., Magnuson B.A. Anthocyanin-rich extracts inhibit multiple biomarkers of colon cancer in rats. Nutr. Cancer. 2006; 54(1): 84-93.
25. Malik M., Zhao C., Schoene N., Guisti M.M., Moyer M.P., Magnuson BA. Anthocyanin rich extract from Aronia meloncarpa E. induces a cell cycle block in colon cancer but not normal colonic cells. Nutr. Cancer. 2003; 46(2):186.
26. Bell D.R., Gochenaur K. Direct vasoactive and vasoprotective properties of anthocyanins-rich extracts. J. Appl. Physiol. 2006; 100(4): 1164-1170.
27. Han G.L., Li C.M., Mazza G., Yang X.G. Effect of anthocyanins rich fruit extract on PGE2 produced by endothelial cells. Journal of Hygiene Research/Wei Sheng Yan Jiu. 2005; 34(5): 581-584.
28. Valcheva-Kuzmanova S., Marazova K., Krasnaliev I., Galunska B., Borisova P., Belcheva A. Effects of Aronia melanocarpa fruit juice on indomethacin induced gastric mucosal damage and oxidative stress in rats. Exp. Toxicol. Pathol. 2005; 56(6): 385-392.
29. Ohgami K., Ilieva I., Shiratori K., Koyama Y., Xue-Hai J., Yoshida K., Kase S., Kitaichi N., Suzuki Y., Tanaka T., Ohno S. Anti- inflammatory effects of Aronia extracts on rat endotoxin-induced uveitis. Invest Ophthamol Vis. Sci. 2005; 46(1): 275-281.
30. Valcheva-Kuzmanova S., Borisova P., Galunska B., Krasnaliev I., Belcheva A. Hepatoprotective effect of the natural fruit juice from Aronia melanoarpa on carbon tetrachloride-induced acute liver damage in rats. Exp Toxicol. Pathol. 2004; 56(3): 195-201.
31. Leung A.Y., Foster S. Encyclopedia of Common Natural Ingredients Used in Food, Drugs, and Cosmetics. 2nd ed. New York: John Wiley and Sons Inc.; 1996. p.113-114.
32. Blumenthal M., Busse W.R., Goldberg A., Gruenwald J., Hall T., Riggins C.W., Rister R.S editors, Klein S. Rister R.S. (trans). The Complete German Commission E Monographs: Therapeutic Guide to Herbal Medicines. Austin: American Botanical Council, Boston: Integrative Medicine Communication; 1998.
33. Warrier P.K, Nambiar V.P.K., Ramankutty C. Indian Medicinal Plants. Vol. 1-5. Madras: Orient Longman Ltd.; 1993-1995.
34. Cragg G., Suffness M. Metabolism of plant-derived anti-cancer agents. Pharmacol. Ther. 1988; 37: 425-432.
35. Cragg G.M., Newman D.J. Plants as source of anticancer agents. J. Ethnopharmacol. 2005; 100(1-2): 72-79.
36. Grubbs C.J., Steele V.E., Casebolt T., Juliana M.M., Eto I., Whitaker L.M., Dragnev K.H., Kelloff G.J., Lubet R.L. Chemoprevention of chemically-induced mammary carcinogenesis by indole-3-carbinol.Anticancer Research. 1995; 15(3): 709-716.
37. Michnovicz J.J. Increased estrogen 2-hydrozylation in obese women using oral indole-3-carbinol. International Journal of Obesity and Related Metabolic Disorders. 1998; 22: 227-229.
38. Yuan F., Chen D.Z., Liu K., Sepkovic D.W., Bradlow H.L., Auborn K. Anti-estrogenic activities of indole-3-carbinol in cervical cells: Implication for prevention of cervical cancer. Anticancer Res. 1999; 19(3A): 1673-1680.
39. Gupta S., Ahmad N., Mukhtar H. Prostate chemoprevention by green tea. Seminars in Urologic Oncology. 1999; 17: 70-76.
40. Taylor J.R, Wilt V.M. Probable antagonism of warfarin by green tea. Ann. Pharmacother. 1999; 33: 426-428.
41. Katiyar S.K., Ahmad N., Mukhtar H. Green tea and skin. Arch. Dermatol. 2000; 136(8): 989-994.
42. Cao Y., Cao R. Angiogenesis inhibited by drinking tea (letter to the editor). Nature. 1999; 381(6726): 398.
43. Jowi A.C. National Research Council of the Philippines-Department of Science and Technology-NRCP-DOST. Available at http://nrcp.dost.gov.ph. 2008.
44. Virmani O.P., Srivastava G.N., Singh P. Catharanthus roseus- the tropical periwinkle. Indian Drugs. 1978; 15: 231-252.
45. Yu X.Y. A prospective clinical study on reversion of 200 precancerous patients with hua-sheng-ping. Zhongguo Zhong Xi Yi Jie He Za Zhi Zhongguo Zhongxiyi Jiehe Zazhi. 1993; 13(3): 147–149.
46. Vladimir B., Majeed M. Nutrition Industry Executive, The Business Magazine for Dietary Supplement Industry Manufacturers; 2004.
47. James P.M. Coleus forskohlii: A nonstimulant herb with proven fat burning ability. Dynamic Chiropractic 2003; 21:12.
48. Ohsumi K., Nakagawa R., Fukuda Y., Hatanaka T., Morinaga Y., Nihei Y., Ohishi K., Suga Y., Akiyama Y., Tsuji T. New combretastatin analogues effective against murine solid tumors: design and structure-activity relationship. J. Med. Chem. 1998; 41: 705-706.
49. Pettit G.R., Singh S.B., Boyd M.R., Hamel E., Pettit R., Schmit J.M., Hogan F. Antineoplastic agents 291: Isolation and synthesis of combretastatins A-4, A-5 and A-6. J. Med. Chem. 1995; 38: 1666-1672.
50. Abdullallaev J.F., Caballero O.H., Riveron N.L., Pereda M.R., Rivera L.R., Manuel H.J., Perez L.I., Espinosa A.J.J. Rev. Invest. Clin. 2002; 54: 430.
51. Yeung H.C. Handbook of Chinese Herbs and Formulas. Vol. 2. Los Angeles: Institute of Chinese Medicine; 1985. p.183.
52. Duke J.A., Ayensu E.S. Medicinal Plants of China. Vol. 2. Algonac: Reference Publications, Inc.; 1985. p.381.
53. Bown D. Encyclopaedia of Herbs and their Uses. London: Dorling Kindersley; 1995. p.53-100.
54. Kai H., Koine T., Baba M., Okuyama T. Pharmacological effects of Daphne genkwa and chinese medical prescription, Jyu-So-To. J. Pharmaceutical Soc., Japan. 2004; 124(6): 349-354.
55. Thakur R.S., Puri H.S., Husain A. Major Medicinal Plants of India. Lucknow: CIMAP; 1989. p.21.
56. Suzuki R., Kohno H., Sugie S., Sasaki K., Yoshimura T., Wada K., Tanaka T. Preventive effects of extract of leaves of ginkgo (Ginkgo biloba) and its component bilobalide on azoxymethane induced colonic aberrant crypt foci in rats. Cancer Lett. 2004; 210(2):159-169.
57. Clewer H.W.B., Green S.J., Tutin F. Constituents of Gloriosa superba. J. Chem. Soc. 1915; 107: 835-846.
58. Hakkak R., Korourian S., Shelnutt S.R., Lensing S., Ronis M.J.J., Badger T.M. Diets containing whey proteins or soy protein isolate protect against 7, 12-dimethylbenz(a) anthracene-induced mammary tumors in female rats. Cancer Epidemiology Biomarkers & Prevention. 2000; 9(1): 113-117.
59. Mc. Michael-Phillips D.F., Harding C., Morton M., Roberts S.A., Howell A., Potten C.S., Bundred N.J. Effects of soy-protein supplementation on epithelial proliferation in the histologically normal human breast. Am. J. Clin. Nutr. 1998; 68(6): 1431-1435.
60. Petrakis N.L., Barnes S., King E.B., Lowenstein J., Wiencke J., Lee M.M., Miike R., Kirk M., Coward L. Stimulatory influence of soy protein isolate on breast secretion in pre-and postmenopausal women. Cancer Epidemiology, Biomarkers & Prevention. 1996; 5(10): 785-794.
61. Odigie I.P., Ettarh R.R., Adigun S.A. Chronic administration of aqueous Hibiscus sabdariffa attenuates hypertension and reverses cardiac hypertrophy in 2k-1c hypertensive rats. J. Ethnopharmacol. 2003; 86(2-3): 181-185.
62. Olaleye M.T. Cytotoxicity and antibacterial activity of methanolic extract of Hibiscus sabdariffa. J. Med. Plants Research. 2007; 11: 9-13.
63. Amin A., Hamza A.A. Hepatoprotective effect of Hibiscus, Rosmarinus and Salvia on azathioprine-induced toxicity in rats. Life Sci. 2005; 77(3): 266-278.
64. Brunold C., Deters A., Knoepfel-Sidler F., Hafner J., Muller B., Hensel A. Polysaccharides from Hibiscus sabdariffa flowers stimulate proliferation and differentiation of human keratinocytes. Planta Med. 2004; 70(4): 370-373.
65. Tseng T.H., Hsu J.D., Lo M.H., Chu C.Y., Chou F.P., Huang C.L., Wang C.J. Inhibitory effect of Hibiscus Protocatechuic acid on tumor promotion in mouse skin. Cancer Lett. 1998; 126(2): 199-207.
66. Nagarjuna Research Foundation. Chengazhuneer Kizhangu. Express Week; dt.: 2/5/98.
67. Sivarajan V.V., Indira B. Ayurvedic Drugs and their Plant Sources. New Delhi: Oxford & IBH publishing Co. Ltd.; 1994. p.315.
68. Newall C.A., Anderson L.A., Phillipson J.D. Herbal Medicine: AGuide for Health Care Professionals. London: Pharmaceutical Press; 1996. p.87-89.
69. Anesini C., Ferraro G., Lopez P., Borda E. Different intracellular signals coupled to the antiproliferative action of aqueous crude extract from Larrea divaricata Cav. and nor-dihydroguaiaretic acid on a lymphoma cell line. Phytomedicine. 2001; 8(1): 1-7.
70. McDonald R.W., Bunjobpon W., Liu T., Fessler S., Pardo O.E., Freer I.K., Glaser M., Seckl M.J., Robins D.J. Synthesis and anticancer activity of nordihydroguaiaretic acid (NDGA) and analogues. Anticancer Drug Design. 2001; 16(6): 261-270.
71. Omoregbe R.E., Ikuebe O.M., Ihimire I.G. Antimicrobial activity of some medicinal plants extracts on Escherichia coli, Salmonella paratyphi and Shigella dysenteriae. Afr. J. Med. Sci. 1996; 25(4): 373-375.
72. Lee-Huang S., Huang P.L., Bourinbaiar A.S., Chen H.C., Kung H.F. Inhibition of the integrase of human immunodeficiency virus (HIV) type 1 by anti-HIV plant proteins MAP30 and GAP31. Proc. Natl. Acad. Sci. 1995; 92(19): 8818–8822.
73. Nagasawa H., Watanabe K., Inatomi H. Effects of bitter melon (Momordica charantia) or ginger rhizome (Zingiber offifinale Rosc.) on spontaneous mammary tumorigenesis in SHN mice. Am. J. Clin. Med. 2002; 30(2-3): 195-205.
74. Chiampanichayakul S., Kataoka K., Arimochi H., Thumvijit S., Kuwahara T., Nakayama H., Vinitketkumnuen U., Ohnishi Y. Inhibitory effects of bitter melon (Momordica charantia Linn.) on bacterial mutagenesis and aberrant crypt focus formation in the rat colon. J. Med. Invest. 2001; 48(1-2): 88.
75. Badary O.A., Al-Shabanah O.A., Nagi M.N., Al-Rikabi A.C., Elmazar M.M. Inhibition of benzo (a) pyrene-induced forestomach carcinogenesis in mice by thymoquinone. Eur. J. Cancer Prev. 1999; 8: 435-440.
76. Salomi N.J., Nair S.C, Jayawardhanan K.K., Varghese C.D., Panikkar K.R. Antitumor principles from Nigella sativa seeds. Cancer Letters. 1992; 63: 41-46.
77. Stoneham M., Goldacre M., Seagroatt V., Gill L. Olive oil, diet and colorectal cancer: an ecological study and a hypothesis. J. Epidemio. Community Health. 2000; 54(10): 756-760.
78. Weisburger J.H., Reddy B.S., Rose D.P., Cohen L.A., Kendall M.E., Wynder E.L. Protective mechanisms of dietary fibers in nutritional carcinogenesis. Basic Life Sci. 1993; 61: 45-63.
79. Bomser J., Madhavi D.L., Singletar K., Smith M.A. In vitro anticancer activity of fruit extracts from Vaccinium species. Planta Medica. 1996; 62(3): 212-216.
80. Harkins K. What’s the use of cranberry juice? Age and Ageing. 2000; 29(1): 9-12.
81. Gerber M. Fiber and breast cancer: another piece of the puzzle-but still an incomplete picture. J. Natl. Cancer Inst. 1996; 88(13): 857-858.
82. Blanchan N. Wild Flowers: An Aid to Knowledge of our Wild Flowers and their Insect Visitors. Project Gutenberg Literary Archive Foundation; 2002.
83. Moraes R.M., Lata H., Bedir E., Maqbool M., Cushman K. On american mayapple as practical source of podophyllotoxin. In: Janick J., Whipkey A. editors. Trends in New Crops and Uses. Alexandria, VA: ASHS Press; 2002. p.527-532.
84. Phillips R., Foy N. Deals with all types of herbs including medicinal, culinary, scented and dye plants. Excellent photographs with quite good information on each plant. London: Herbs Pan Books Ltd; 1990. p. 245.
85. Stahelin H. Activity of a new glycosidic lignan derivative (VP 16- Vijaya T. S. et al., Journal of Global Pharma Technology. 2009; 1(1): 4-18 213) related to podophyllotoxin in experimental tumors. Eur. J. Cancer. 1973; 9: 215-221.
86. Koya-Miyata S., Kimoto T., Micallef M.J., Hino K., Taniguchi M., Iwaki K., Ikeda M., Kurimoto M. Prevention of azoxymethane induced intestinal tumors by a crude ethyl acetate extract and tryptanthrin extracted from Polygonum tinctorium Lour. Anticancer Res. 2001; 21(5): 3295-3300.
87. Meijer L., Raymond E. Roscovitine and other purines as kinase inhibitors from starfish oocytes to clinical trials. Accounts Chem. Res. 2003; 36: 417-425.
88. Chopra R.N., Nayar S.L., Chopra I.C. Glossary of Indian Medicinal Plants. New Delhi: Council of Scientific and Industrial Research; 1956. p.77-100.
89. Wu P.L., Lin S.B., Huang C.P., Chiou R.Y.Y. Antioxidative and cytotoxic compounds extracted from the sap of Rhus succedanea. J. Nat. Prod. 2002; 65(11): 1719-1721.
90. Ahn Y.O. Diet and stomach cancer in Korea. Int. J. Cancer. 1997; 10: 7-9.
91. Moerman D. Native American Ethnobotany 1st ed. Oregon: Timber Press; 1998. p.453-459.
92. Husain A., Virmani O.P., Popli S.P., Misra L.N., Gupta M.M., Srinvastava G.N., Abraham Z., Singh A.K. Dictionary of Indian Medicinal Plants. Lucknow: CIMAP; 1992. p.546.
93. Foster S., Duke J.A. A Field Guide to Medicinal Plants. New York: Houghton Mifflin; 1990. p.46.
94. Tyler V.E. The Honest Herbal. 3rd ed. Binghamton, NY: Pharmaceutical Products Press; 1993. p.158-169.
95. Govers M.J., Gannon N.J., Dunshea F.R., Gibson P.R., Muir J.G. Wheat bran affects the site of fermentation of resistant starch and luminal indexes related to colon cancer risk: a study in pigs. Gut. 1999; 45(6): 840-847.
96. Consensus Statement on Cereals, Fibre and Colorectal and Breast Cancers Proceeding of the European Cancer Prevention Consensus Meeting. Santa Margheritia, Italy. Eur. J. Cancer Prev. 1998; 7(2): S1-S83.
97. Duke J.A. The Green Pharmacy. Emmaus, PA: Rodale Press Inc.; 1997. p.7-81.
98. Robbers J.E., Tyler V.E. Tyler’s Herbs of Choice: The Therapeutic Use of Phytomedicinals. New York: The Haworth Herbal Press; 1999. p.51-123.
99. Chung H.K., Choi S.M., Ahn B.O., Kwak H.H., Kim J.H., Kim W.B. Efficacy of troxerutin on streptozotocin induced rat model in the early stage of diabetic retinopathy. Arzneimittelforschung. 2005; 55(10): 573-580.
100. Fursova A.Z., Gesarevich O.G., Gonchar A.M., Trofimova N.A., Kolosova N.G. Dietary supplementation with bilberry extract prevents macular degeneration and cataracts in senesce-accelerated OXYS rats. Adv. Gerontol. 2005; 16:76-79.
101. Roy S., Khanna S., Alessio H.M., Vider J., Bagchi D., Bagchi M., Sen C.K. Anti-angiogenic property of edible berries. Free Radic. Res. 2002; 36(9): 1023-1031.
102. Cazacu M., Oniu T., Lungoci C., Mihailov A, Cipak A., Klinger R., Weiss T., Zarkovic N. The influence of Isorel on the advanced colorectal cancer. Cancer Biother. Radiopharm. 2003; 18: 27-34.
103. Diaz F., Chavez D., Lee D., Mi Q., Chai H.B., Tan G.T., Kardono L.B.S., Riswan S., Fairchild C.R., Wild R., Farnsworth N.R., Cordell G.A., Pezzuto J.M., Kinghorn A.D. Cytotoxic flavones analogues of vitexicarpin, a constituent of the leaves of Vitex negundo. J. Nat. Prod. 2003; 66(6): 865-867.
104. Butlet M.S. The role of natural product chemistry in drug discovery. J Nat Prod. 2004; 67: 2141-2153.
105. Oberlines N.H., Kroll D.J. Camptothecins and taxol: historic achievement in natural products research. J Nat Prod. 2004; 67: 129-135.
Herbs and Spices in Cancer Prevention and Treatment
Herbal Medicine: Biomolecular and Clinical Aspects. 2nd edition.
Christine M. Kaefer and John A. Milner.
Historically, spices have shaped many events throughout the world. Many voyagers, including the legendary Christopher Columbus, explored the seas in search of treasured spices. These valued commodities contribute not only flavors but also serve as colorants and preservatives in a wide variety of cultures. Today, spices are increasingly revered not only for their culinary properties but also for their potential health benefits. Although the health attributes associated with spice use may arise from their antioxidant properties, their biological effects may arise from their ability to induce changes in a number of cellular processes, including those involved with drug metabolism, cell division, apoptosis, differentiation, and immunocompetence.
The complexity of understanding the biological response to spices first surfaces in the criteria used to distinguish what constitutes a culinary spice and how they differ from culinary herbs. These terms are often used interchangeably in the scientific and lay literature. The U.S. Food and Drug Administration (FDA) defines a spice as an “aromatic vegetable substance, in the whole, broken, or ground form,” whose significant function in food is “seasoning rather than nutrition” and from which “no portion of any volatile oil or other flavoring principle has been removed” (Food and Drug Administration 2007:205-208). While this is a viable definition, it does not consider the biological consequences of consuming these items and how they differ from herbs. The U.S. National Arboretum offers an alternative definition and describes spices as “flavorings (often of tropical origin) that are dried and culinary herbs that are fresh or dried leaves from plants which can be used for flavoring purposes in food preparation” (United States National Arboretum 2002). We must remember that the quantity of an item consumed does not dictate its importance. Thus, to avoid the health significance in any definition would appear flawed. In this chapter, we use the terms “herbs” and “spices” interchangeably and assume that both have properties that extend beyond simply providing flavor and color.
There is little doubt that nutrition and health are intimately linked (Kennedy 2008). For generations, people have alleged that foods provide greater benefits than simply supplying energy. Beliefs in the medicinal properties of foods have surfaced in many early writings of man. Hippocrates is frequently quoted as having said “Let food be thy medicine and medicine be thy food.” Epidemiological, preclinical, and clinical studies continue to provide fundamental insights into the dynamic relationships between nutrients—defined here as any substance in the diet that brings about a physiological effect—and health. Today, claims about the ability of foods, including spices, to lower disease risk or to enhance the quality of life continue to captivate our lives (Kaefer and Milner 2008; Kochhar 2008; Krishnaswamy 2008; Iyer et al. 2009). Three types of biomarkers— exposure, effect, and susceptibility—are needed to evaluate the effects of spices in cancer prevention and therapy (Figure 17.1). Additional information about the amounts of specific spices required to bring about a response (effect) and the interactions of spices with other constituents of the diet, microbes in the gastrointestinal tract, environmental exposures, and human genetics (susceptibility factors) will be needed to unravel the true benefits of adding spices to the diet.
(See color insert.) Three types of biomarkers (exposure, effect, and susceptibility) are needed to assess the benefits or risk of spices.
Spices may be a key to determining the balance between pro- and anticancer factors that regulate risk and tumor behavior (Figure 17.2). About 75% of U.S. households use dietary approaches to reduce their risk of diseases, including cancer (Sloan 2005). Americans between the ages of 36 and 55 are increasingly interested in adopting healthy eating behaviors and are gravitating toward ethnic cuisines based on perceived health benefits (Uhl 2000). Many of these ethnic foods are loaded with unique and flavorful spices; however, while dietary guidelines in several countries tend to support the incorporation of spices into diets, quantifiable recommendations for specific amounts have not yet been forthcoming (Tapsell et al. 2006).
Multiple factors may influence the need for spices for reducing the risk of cancer or changing the biological behavior of cancerous cells.
Between 1970 and 2005, the overall per capita consumption of spices in the United States doubled, increasing from about 1.6 to 3.3 pounds per year (United States Department of Agriculture Economic Research Service, 2007). As expected, the consumption of some spices increased far more than others; for example, garlic consumption increased more than sixfold. According to a report by Buzzanell (1995) from the United States Department of Agriculture’s (USDA) Economic Research Service, the increasing domestic use of spices reflects a number of factors. Among these are the growing Hispanic and Asian populations within the United States, an increasing trend toward the use of culinary herbs and spices to compensate for less salt and lower fat foods and a general increase in the popularity of ethnic foods.
This chapter reviews culinary herbs and spices for their ability to modify several cellular processes that are linked to the risk of cancer and/or tumor behavior (Figure 17.3). The ability of spices to serve as inhibitors of carcinogen bioactivation, decrease free radical formation, suppress cell division and promote apoptosis in cancerous cells, suppress microbial growth, and regulate inflammation and immunocompetence will be discussed as plausible mechanisms by which selected spices may promote health and disease resistance. The low toxicity and wide acceptance of spices may make them particularly useful as a subtle personal dietary change that may decrease risk for several diseases. It is already appreciated that the addition of about 1 g/day of herbs to one’s diet can significantly contribute to total antioxidant intake (>1 mmol) and offers a better source of antioxidants than many food items (Dragland et al. 2003; see also Chapter 2 on antioxidants in herbs and spices). Because several spices are effective antioxidants, they may be particularly important in decreasing oxidative damage due to environmental stress, including excess calorie intake.
Multiple cancer-related processes may account for the ability of spices to inhibit experimentally induced cancers. While these processes are likely critical for determining the risk of cancer and tumor behavior in humans, only limited clinical evidence (more...)
More than 180 spice-derived compounds have been identified and explored for their health benefits (Aggarwal et al. 2008). It is beyond the scope of this chapter to deal with all herbs and spices that may influence the risk of cancer and tumor behavior. Therefore, a decision was made to review those with some of the more impressive biological responses reported in the literature, and a conscious effort was made to provide information about the amount of spices needed to bring about a response and thus their physiological relevance. When possible, recent reviews are included to provide readers with additional insights into the biological response(s) to specific spices and to prevent duplication of the scientific literature. Because there is a separate chapter devoted to curcumin (a bioactive component in turmeric) in this book and there are also several excellent reviews published about curcumin (Patel and Majumdar 2009; Aggarwal 2010; Bar-Sela, Epelbaum, and Schaffer 2010; Epstein, Sanderson, and Macdonald 2010), turmeric is not discussed in this chapter.
The term “allspice” was coined in the 1600s by the English, who thought the herb combined the flavors of cinnamon, nutmeg, and cloves. Allspice is also referred to as “Jamaica pepper,” “kurundu,” “myrtle pepper,” “pimenta,” and “newspice.” Ground allspice is not a mixture of spices as some still believe, but arises from the dried unripe berries of the tree Pimenta dioica. This tree is native to the Greater Antilles, southern Mexico, and Central America. Today, P. dioica is cultivated in many warm areas throughout the world. Allspice is also available commercially as an essential oil.
Allspice is claimed to possess antimicrobial, antioxidant, anti-inflammatory, analgesic, antipyretic, anticancer, and antitumorigenic properties (Rompelberg et al. 1996; Al-Rehaily et al. 2002; Kluth et al. 2007). It contains a multitude of potential bioactive agents that may contribute to health promotion, including flavonoids, phenolic acids, catechins, and several phenylpropanoids (Al-Rehaily et al. 2002). Berries contain about 2-5% essential oils that include the following bioactive compounds: eugenol (60-75%), eugenol methyl ether, cineole (eucalyptol), phellandrene, and caryophyllenes (Kluth et al. 2007). The antioxidant and antimicrobial activities of allspice may be associated with eugenol (Rompelberg et al. 1996; Kluth et al. 2007).
Billing and Sherman (1998) reported that allspice was as effective as garlic and onions in suppressing microbial growth. The significance of its antimicrobial properties was recently highlighted by evidence that allspice and eugenol were effective in lowering the virulence of Escherichia coli O157:H7 (Takemasa et al. 2009). Nevertheless, there are concerns that allspice oil can be toxic and promote inflammation, nausea, and vomiting when consumed in excess.
The anticancer properties of allspice may be in part due to its ability to influence cytochrome P450 (CYP) activity and thereby influence carcinogen bioactivation. Kluth et al. (2007) cultured human liver carcinoma cells and human colon adenocarcinoma cells and studied the ability of the spice extract to activate mechanisms related to phase I detoxification enzymes. The allspice extract (3 mg/mL in dimethyl sulfoxide) did not activate pregnane X receptor (PXR) directly but did strongly activate the CYP3A4 promoter. Thus, the activation of transcription factors to bind to response elements seems like a plausible mechanism by which allspice, and potentially eugenol, function. There is specificity in the response to allspice and eugenol because gastrointestinal glutathione peroxidase (GPx), a phase II enzyme linked to removal of reactive oxygen species (ROS), was not influenced by allspice or eugenol (Kluth et al. 2007).
Inflammation is linked to increased risk of cancer (Dinarello 2010) and appears to be influenced by allspice consumption. Although controlled clinical interventions are not available, evidence in rodents suggests potency (Al-Rehaily et al. 2002). Providing an oral allspice suspension (500 mg/kg body weight) significantly inhibited carrageenan-induced paw edema and cotton pellet granuloma in rats. It also suppressed acetic acid-induced writhing and tail flick reaction time and decreased yeast-induced hyperpyrexia in mice. Interestingly, the suspension also appeared to have antiulcer and cytoprotective activity in rats by protecting gastric mucosa against indomethacin and various necrotizing agents, including 80% ethanol, 0.2 M sodium hydroxide (NaOH), and 25% sodium chloride (NaCl), suggesting that it might also have an impact on cyclooxygenase (COX) activity. It remains unclear what molecular target alteration(s) account for this response.
Evidence exists that allspice can alter the proliferation of several cultured cancerous cells. While cell viability was reduced about 50% when allspice extract was added to prostate cancer cells (LNCaP cells), it did not influence the viability of cultured human prostate cancer cell lines (DU145) or cervical epithelial carcinoma (HeLa) cells (Lee et al. 2007). The mechanism by which allspice leads to cellular growth depression remains largely unresolved. However, recent studies by Lee et al. (2007) suggest that epigenetics may be involved. A depression in histone acetyltransferase (HAT) activity may be involved. Androgen-induced HAT activity was decreased by 70% when allspice was provided at 100 μg/mL. Allspice also suppressed androgen receptor (AR) acetylation in LNCaP cells and significantly decreased histone H3 and H4 acetylation, indicating that a repression of AR-mediated transcription was induced due to shifts in histone and nonhistone acetylation. While these in vitro studies are intriguing, there is a need for controlled interventions in animal models before exploring allspice’s potential benefit as a dietary antitumorigenic agent.
Basil (Ocimum basilicum) is a culinary herb prominently featured in Italian and Southeast Asian cuisines. While many varieties of basil exist, sweet basil is one of the most predominant and most frequently examined herbs for its health benefits. Basil is originally native to Iran, India, and other tropical regions of Asia, but now it is widely available throughout the world. Basil’s antioxidant, antimutagenic, antitumorigenic, antiviral, and antibacterial properties likely arise from a variety of components including linalool, 1,8-cineole, estragole, and eugenol (Muller et al. 1994; Chiang et al. 2005; Makri and Kintzios 2007). Similar to most culinary spices, far more information is needed about the variation in content of constituents as a function of plant varietal, growing conditions, and processing.
The essential oil of basil possesses antimicrobial properties (Wannissorn et al. 2005). Moghaddam, Karamoddin, and Ramezani (2009) investigated the effect of basil on Helicobacter pylori and found that methanol, butanol, and n-hexane fractions of basil demonstrated antagonistic activity against the bacteria (MIC = 39-117 μg/disk). While not as potent as amoxicillin, its effectiveness raises possibilities of using individual or multiple spices as potent antimicrobials, especially in areas where commercial antibiotics are in limited supply (Moghaddam, Karamoddin, and Ramezani 2009).
The effects of basil are not limited to its antimicrobial properties because evidence indicates that it also can lower oxidative damage in animal models (Dasgupta, Rao, and Yadava 2004). Feeding mice 200 and 400 mg/kg body weight with a hydroalcoholic extract of basil leaves for 15 days markedly increased GPx (1.22-1.4 fold), glutathione (GSH) reductase (1.16-1.28 fold), catalase (1.56-1.58 fold), and superoxide dismutase (1.1-1.4 fold; Dasgupta, Rao, and Yadava 2004). The change in activity in one or more of these enzymes may explain the decrease in lipid peroxidation caused by basil in studies by Dasgupta, Rao, and Yadava (2004). Drăgan et al. (2007) examined the effects of balsamic vinegar–enriched extracts from several herbs (rosemary, sage, and basil) in soups and salads on oxidative stress and quality of life measures in women with stage IIIB and IV breast cancer. While there was a decrease in oxidative stress, the complexity of the dietary intervention made it impossible to determine the component(s) that led to improvements.
Several studies provide evidence that basil is an antimutagenic spice (Kusamran, Tepsuwan, and Kupradinun 1998; Stajkovic et al. 2007). Stajkovic et al. (2007) studied the antimutagenic effects of basil on mutagenicity in Salmonella typhimurium TA98, TA100, and TA102 cells in the presence or absence of liver microsomal activation. The essential oil of basil, at concentrations ranging from 0.5 μL/plate to 2.0 μL/plate, inhibited mutations from ultraviolet irradiation (dose = 6 J/m2) by 22-76%. Mutations caused by 4-nitroquinoline-N-oxide (0.15 μg/plate) were decreased by 23-52%, and those from 2-nitropropane (14.9 mg/plate) by 8-30%. These findings are consistent with studies by Jeurissen et al. (2008), who demonstrated that 50 μg/mL basil largely blocked DNA adduct formation caused by 1′-hydroxyestragole in the human hepatoma (HepG2) cell line, possibly by promoting phase II enzymes and thereby conjugation and elimination of this carcinogen. These findings likely explain the ability of basil to decrease the mutagenicity of aflatoxin B1 (AFB1) and benzo(a)pyrene (B(a)P) (Stajkovic et al. 2007). The mutagenicity of AFB1 was inhibited by >30% by the presence of 1-2 mg/plate of a hexane-based basil extract and 0.5-1 mg/ plate of chloroform- and methanol-based basil extracts. Because B(a)P mutagenicity was only inhibited by chloroform- and methanol-based basil extracts at doses of 2-5 mg/plate, multiple constituents might be responsible for basil’s antimutagenic activities.
The anticancer properties of basil in preclinical studies are mixed. In studies with Sprague-Dawley rats fed with an AIN-76 diet with or without high concentrations of basil (6.25% and 12.5%), there was no clear indication of a decrease in 9,10-dimethyl-1,2-benzathracene (DMBA)-induced mammary cancer. It is unclear whether the quantity of the procarcinogen examined, the simultaneous induction of both phase I and II enzymes, or some other factors accounted for the lack of protection by adding basil to the animals’ diet (Kusamran, Tepsuwan, and Kupradinun 1998). Nevertheless, there is evidence that basil can decrease DMBA-induced carcinogenesis. Providing Swiss mice with a diet containing 150 or 300 mg/kg body weight of basil extract decreased DMBA-induced skin tumors (12.5% reduction and 18.75% reduction for lower and higher doses, respectively), and lowered the tumor burden per mouse. Compared to the average number of tumors per mouse in the controls, the tumor burden was approximately 2.4 times lower (p < .01) in the low-dose basil group and 4.6 times lower (p < .001) in the high-dose basil group (Dasgupta, Rao, and Yadava 2004). It is unclear whether differences in the response between mice and rats reflect the species, the cancer site, or the dietary or procarcinogen exposures.
DNA methyltransferase (MGMT) is a critical repair protein in the cellular defense against alkylation damage. MGMT is highly expressed in human cancers and in tumors resistant to many anticancer alkylating agents. Niture, Rao, and Srivenugopal (2006) examined the ability of several medicinal plants to upregulate O6-methylguanine adducts. Both ethanol and aqueous extracts of basil increased MGMT protein levels in HT29 human colon carcinoma cell lines 1.25-fold compared to controls after 72-hours incubation. Compared to the control, basil increased glutathione-S-transferase (GST) protein activity 1.33-fold after 12 hours of incubation; after 24 hours, GST activity increased 1.68-fold compared to the control, which declined to 1.47-fold after 72 hours incubation. Because MGMT is one of the body’s first lines of defense against alkylation DNA damage, a small increase (two- to threefold) in this enzyme may protect against mutagenic lesions (Niture, Rao, and Srivenugopal 2006).
The anticancer properties of basil may also relate to its ability to influence viral infections. Individuals with hepatitis B are recognized to be at increased risk for hepatocellular carcinoma (Fung, Lai, and Yuen 2009; Ishikawa 2010). Chiang et al. (2005) evaluated the antiviral activities of basil extract and selected basil constituents in a human skin basal cell carcinoma cell line (BCC-1/ KMC) and a cell line derived from hepatoblastoma HepG2 cells (2.2.15) against several viruses, including hepatitis B. Impressively, Chiang et al. (2005) found that the aqueous extract of basil, along with apigenin and ursolic acid, displayed greater anti-hepatitis B activity than two commercially available drugs, glycyrrhizin and lamivudine (3TC). Overall, these studies raise intriguing questions about the merits of using commercially available spices to retard viruses and potentially cancer. Undeniably, much more information is needed to clarify the amounts and durations needed to bring about a desired viral response and the mechanism by which a response occurs.
It should be noted that there are concerns about excess basil exposure. Estragole, a suspect procarcinogen/mutagenic found in basil, raises questions about the balance between benefits and risks with the use of this and other spices (Muller et al. 1994). Now, the majority of evidence points to the antimutagenic effects of basil outweighing the potential adverse effects associated with estragole-induced cell damage (Jeurissen et al. 2008).
Caraway (Carum carvi), also known as “meridian fennel” or “Persian cumin,” is native to western Asia, Europe, and northern Africa. The principal agents in caraway oil are believed to be carvone or p-mentha-1,8-dien-2-one and limonene or p-mentha-1,8-diene, the precursors of carvone and anethofuran (Zheng, Kenney, and Lam 1992). Although caraway appears to be a potent antioxidant in vitro, it has not been adequately examined in humans. Recently, Kapoor et al. (2010) showed that caraway essential oil and oleoresins were progressively effectively with dose as antioxidants and more effective than commercial butylated hydroxyanisole and butylated hydroxytoluene. Caraway oil and its ethanol oleoresin showed better reductive power than the other oleoresins. The scavenging and reducing power against the diphenylpicrylhydrazyl (DPPH) radicals that caraway oil and oleoresins provide may be associated with their ability to donate hydrogen and the presence of reductones.
Mazaki et al. (2006) examined the effect of caraway seed extract on mutagenesis induced by N-methyl- N-nitro-N′-nitrosoguanidine (MNNG) in S. typhimurium strains that are deficient in DNA MGMT. Their results indicated that caraway does not directly inactivate MNNG and O 6-methylguanine-DNA MGMT may be involved in the response. Animal models have also been used to explore the anticancer potential of caraway in sites ranging from colon to skin cancers. Schwaireb (1993) examined dietary caraway oil for its effects on skin tumors induced by DMBA and croton oil in female BALB/c mice. Mice fed with a diet containing 3% caraway oil for 23 weeks from the beginning of tumor promotion decreased the number of mice with papillomas (p < .001), the number of papillomas per mouse (p < .0001), and the average papilloma volume (p < .0001). The number of carcinomas in those animals provided with caraway oil were significantly less than in the controls (Schwaireb 1993). Deeptha et al. (2006) examined the effects of oral caraway (30, 60, and 90 mg/kg body weight per day for 15 weeks) on aberrant crypt foci in male Wistar rats treated with the carcinogen 1,2-dimethylhydrazine. Aberrant foci are early morphological events that represent an important step in colon cancer progression. Treatment of rats with 60 mg/kg body weight of caraway decreased carcinogen-induced aberrant crypt foci, indicators of oxidative stress, and fecal bacterial enzyme activity.
Induction of GST by anticarcinogenic compounds is an important mechanism by which several spices, including caraway, may promote carcinogen detoxification and thereby lower cancer risk. Zheng, Kenney, and Lam (1992) reported that activity of the detoxifying enzyme GST in the liver increased markedly after gavage treatment with 20 mg carvone or limonene in A/J mice. Carvone was also found to increase the GST activity in the forestomach by about 80% (p < .05), more than double the GST activity in the large intestinal mucosa (p < .05), and more than triple the GST activity in the small intestinal mucosa (p < .005). Carvone also increased glutathione (GSH) in the lung (p < .005) and in the small (p < .05) and large intestinal mucosa (p < .05).
Caraway may also influence carcinogen activation by its ability to modify carcinogen bioactivation. Polycyclic aromatic hydrocarbons and halogenated aromatic compounds such as 2,3,7,8-tetrodibenzo-p-dioxin (TCDD) are bioactivated by the xenobiotic-metabolizing CYP genes to form reactive metabolites that bind to DNA. Naderi-Kalali et al. (2005) reported that caraway extracts were effective in inhibiting the induction of CYP1A1 and CYP1A1-related RNA in rat hepatoma (H4IIE) cells. Caraway extracts >0.13 μM significantly inhibited CYP1A1 induction, as measured by the 2,3,7-ethoxyresorufin O-deethylase assay, with roughly a tenfold suppression in enzyme activity observed at concentrations of 1.3 and 13 μM, inhibiting TCDD-dependent induction by 50%-90%, depending on the solvent used (Naderi-Kalali et al. 2005). Overall, changes in both phase I and II enzymes are consistent with the ability of caraway and its active constituent to lower chemically induced cancers. The importance of caraway and its isolated components in drug detoxification mechanisms in humans remains largely unexplored.
Cardamom refers to herbs within the Elettaria (green) and Amomum (black) genera of the ginger family Zingiberaceae. Cardamom is a common ingredient used in Indian cooking and in various parts of Europe. As with many spices, cardamom has been demonstrated to have antioxidant properties. Kikuzaki, Kawai, and Nakatani (2001) examined extracts from black cardamom (Amomum subulatum) for their ability to scavenge radicals. The ethyl acetate-soluble fraction, containing several phenolic compounds (protocatechualdehyde, protocatechuic acid, 1,7-bis(3,4-dihydroxyphenyl)hepta- 4E,6E-dien-3-one, and 2,3,7-trihydroxy-5-(3,4-dihydroxy-E-styryl)-6,7,8,9-tetrahydro-5H-benzocycloheptene), scavenged about 90% of DPPH radicals when provided at 100 μg/mL. Interestingly, at lower concentrations, its radical scavenging activity was comparable to that of α-tocopherol (Kikuzaki, Kawai, and Nakatani 2001). Feeding male albino Wistar rats with a high-fat diet supplemented with 10% black cardamom seed powder for 90 days was found to lower 2-thiobarbituric acid reactive substances (TBARS) by 28% (p < .05) in heart tissue (Dhuley 1999). In addition, cardamom caused significant increases (p < .05) in several antioxidant enzymes including catalase, superoxide dismutase, and GST in both liver and heart compared to controls (Dhuley 1999).
The ability of cardamom to inhibit chemical carcinogenesis was shown by Banerjee et al. (1994), who observed cardamom oil feeding (10 μL daily for 2 weeks) caused a significant decrease in liver CYP content in Swiss albino mice (p < .05). A 30% increase in GST activity (p < .05) and sulfhydryl levels (p < .05) in the liver also accompanied the cardamom oil treatment. These observations suggest that intake of cardamom oil affects the enzymes associated with xenobiotic metabolism and may therefore have benefits as a deterrent to cancer (Banerjee et al. 1994). Cardamom has also been demonstrated to decrease azoxymethane-induced colon carcinogenesis by virtue of its anti-inflammatory, antiproliferative, and proapoptotic activities. Providing aqueous cardamom suspensions can enhance detoxifying enzyme (GST activity) and decrease lipid peroxidation (Bhattacharjee, Rana, and Sengupta 2007).
Recently, cardamom aqueous extracts (1, 10, 50, and 100 mg/mL) were reported to significantly enhance splenocyte proliferation in a dose-dependent manner, especially when combined with black pepper (Majdalawieh and Carr 2010). While the effects of cardamom and black pepper were the opposite on T helper-1 and -2 cytokine release by splenocytes, the presence of both spices significantly enhanced the cytotoxic activity of natural killer cells against YAC-1 lymphoma cells. These findings provide evidence that cardamom may have anticancer benefits by modifying immunocompetence.
Cinnamon is a spice obtained from the bark of an evergreen tree belonging to the Lauraceae family. Major constituents in cinnamon include cinnamaldehyde, eugenol, terpinene, α-pinene, carvacrol, linalool, safrole, benzyl benzoate, and coumarin (Tabak, Armon, and Neeman 1999). Cinnamon is widely used in traditional Chinese medicine. Several studies have examined its antioxidant properties. When inbred male albino Wistar rats were fed a high-fat diet with 10% cinnamon bark powder (Cinnamomum verum) for 90 days, oxidative stress was substantially decreased, as evident by a reduction in TBARS, a biomarker of free radical production (Dhuley 1999). Providing rats with cinnamon bark powder significantly increased several antioxidant-related enzymes, including catalase, superoxide dismutase, and GST in both liver and heart tissue, compared to controls. Glucose-6-phosphate dehydrogenase and GPx were also significantly increased (p < .05) in rats fed with cinnamon bark powder. These enzymes help maintain GSH levels, essential for cellular integrity and protection against oxidative damage from free radicals (Dhuley 1999).
The ability of cinnamon extracts to suppress the in vitro growth of H. pylori, a recognized risk factor for gastric cancer, gastric mucosa-associated lymphoid tissue lymphoma, and possibly pancreatic cancer, has stirred considerable interest in the potential use of this spice to suppress human cancers (Farinha and Gascoyne 2005; Eslick 2006). However, a pilot study involving 15 subjects given a cinnamon extract (80 mg/day) for 4 weeks was not effective in those infected with H. pylori (Nir et al. 2000). In this study, the colonization rate of H. pylori was measured by urea breath tests (UBTs). Although a decline in H. pylori counts was observed in six patients with exceptionally high counts according to their first UBT, the study did not demonstrate a decrease in colonization overall, and in some individuals increased colony counts occurred. The lack of success of cinnamon as a single treatment regimen against H. pylori is not terribly surprising given the consistent failure of single-agent antibiotic trials. Additional trials using higher cinnamon amounts and possibly in combination with other agents may be warranted to truly evaluate the effects of this spice (Nir et al. 2000). Tabak et al. (1996) examined several spices for their ability to inhibit H. pylori. Cinnamon and thyme were found to be the most potent inhibitors of H. pylori growth and urease activity. Tabak, Armon, and Neeman (1999) reported cinnamon’s antibacterial activity against seven clinical isolates of H. pylori and the antiurease activity of two different cinnamon extracts (methylene chloride and ethanol) and their chemical constituents. They found that adding 100 μg cinnamon per disk produced an inhibition zone of approximately 80 mm wide, which was greater than the inhibition zones produced by several antibiotics (10 μg ampicillin, 30 μg tetracycline, 15 μg erythromycin, 30 μg nalidixic acid, and 25 μg co-trimoxazole). Although a concentration of 25 μg/mL completely inhibited four H. pylori strains, 50 μg/mL was the minimum inhibitory concentration for all seven strains. In a liquid medium, cinnamon extract began to inhibit H. pylori at a concentration >3 μg/ mL and peaked at a concentration >12 μg/mL, and a similar pattern of inhibition was observed with urease. The efficiency of cinnamon extracts in inhibiting H. pylori in a liquid medium and its resistance to low pH may enhance its effects in an environment like the human stomach. The antibacterial effects of cinnamon extract may be due to cinnamaldehyde. Adding 200 μg cinnamaldehyde per disk produced an inhibition zone >90 mm, while eugenol (2000 μg/disk) produced an inhibition zone of 68 mm, and carvacrol (2000 μg/disk) produced an inhibition zone of 66 mm; Tabak, Armon, and Neeman 1999).
Cao, Urban, and Anderson (2008) studied the role of polyphenolic polymers from commercial cinnamon extract in immune regulation using mouse RAW264.7 macrophages. The authors examined whether cinnamon polyphenol extract (CPE) regulated immune function by affecting expression levels of genes that code for tristetraprolin (TTP/zinc finger protein 36), proinflammatory cytokines, and glucose transporter (GLUT) family proteins, and they compared these effects with that of insulin and lipopolysaccharide. Because TTP downregulates proinflammatory cytokines, it has the potential for use in the prevention and treatment of inflammation-related diseases. In this study, CPE rapidly increased TTP mRNA and protein levels in mouse RAW264.7 macrophages after 30 minutes of treatment, and twofold increase in expression was sustained throughout the 4 hours of treatment. CPE also increased the mRNAs coding for proinflammatory cytokines, such as tumor necrosis factor α, cyclooxygenase-2, and interleukin 6, although the TTP levels were 6- to 3000-fold higher than the proinflammatory cytokine mRNA molecules in the same cells (Cao and Prior 1998). In mammals, glucose is a critically important molecule in the host immune response to injury and infection, which is facilitated by GLUT family proteins, and based on this study, cinnamon increases GLUT expression.
Vascular endothelial growth factor (VEGF) is a critical factor in the induction of angiogenesis. Unfortunately, the side effects associated with most anti-VEGF drugs limit their use, and thus, the use of naturally occurring dietary inhibitors derived from diets has great appeal. A water-based extract from cinnamon is a promising effective agent because it directly inhibits kinase activity of purified VEGFR2 as well as mitogen-activated protein kinase- and Stat3-mediated signaling pathway in endothelial cells (ECs; Lu et al. 2010). Impressively, the extract was found to inhibit VEGF-induced EC proliferation, migration and tube formation in vitro, sprout formation from aortic ring ex vivo, and tumor-induced blood vessel formation in vivo. Polyphenols in the extract appear to be responsible for the response; cinnamaldehyde is observed to have little effect on VEGFR2 kinase activity (Lu et al. 2010). While the ability of cinnamon to influence angiogenesis is intriguing, additional studies are warranted.
Clove is derived from flower buds of the Eugenia caryophyllata tree. Several bioactive components are found in clove, including tannins, terpenoids, eugenol, and acetyleugenol (Kluth et al. 2007). Cloves are native to Indonesia and are used in cuisines throughout the world. While no studies have been conducted in humans to date to evaluate use of cloves in cancer prevention, a few studies conducted in mice suggest its effectiveness, especially in modifying cellular detoxification processes. Feeding 40 mg clove per gram of diet to mice resulted in an increase in GST activity compared to those that were not fed the spice. The physiological significance of these findings remains unclear because the increase was approximately 2% above normal in the liver (not significant), 18% in the stomach (p < .05), and 33% in the esophagus (p < .05; Aruna and Sivaramakrishnan 1990). An increase in GSH concentrations in the stomach also occurred (p < .05), suggesting detoxification of clove constituents in the stomach (Aruna and Sivaramakrishnan 1990). In another study, feeding clove (0.5%, 1%, and 2%) to mice for varying durations (10, 20, and 30 days) modified several phase II enzymes associated with carcinogen bioactivation (Kumari 1991). A dose-dependent response was observed for several detoxification enzymes. After 20 days, all exposures resulted in a significant increase in GST and cytochrome b5 (Kumari 1991). DT-diaphorase was significantly elevated in those that were provided with 1% or 2% clove after 30 days (p < .0005) compared to controls. A significant decrease in CYP activity was observed in those provided with any clove after 30 days. No changes were observed in the activity levels of aryl hydrocarbon hydroxylase in response to the clove administration. Malondialdehyde (MDA) formation was measured to monitor radiation-induced lipid peroxidation, and both the concentration of clove provided and the duration of exposure affected the results. Diets containing 2% clove for at least 20 days, or any concentration administered for 30 days, significantly decreased MDA (Kumari 1991). Eugenol, an allyl chain-substituted guaiacol, may be responsible, at least in part, for the induction of the phase II enzymes (Han et al. 2007) and/or serve as an antioxidant (Rajakumar and Rao 1993; Nagababu and Lakshmaiah 1994). Changes in phase I and II enzymes may account for the ability of eugenol to serve as an antimutagen (Miyazawa and Hisama 2003) and to inhibit carcinogen-induced genotoxicity (Han et al. 2007).
Kluth et al. (2007) examined the influence of several spice extracts on phase I and II enzymes in cultured human liver carcinoma and human colon adenocarcinoma cells, and they suggested a shift in the nuclear transcription factor Nrf2 was responsible for the induction. Evidence also exists that clove extracts might interfere with β-catenin activity and thereby decrease colon carcinogenesis, but further studies are needed on this (Aggarwal 2010).
Similar to allspice, clove contains high amounts of eugenol. However, this compound cannot serve to increase gastrointestinal GPx promoter activity, suggesting other compounds in clove may account for its biological activity (Kluth et al. 2007). Overall, the findings to date suggest that tissues adapt to exposures to one or more constituents in cloves. In doing so, clove may improve the ability of selected tissues to handle foreign compounds that might lead to the initiation of carcinogenesis. Based on findings to date, additional clinical studies are warranted to determine the ability of clove to influence drug detoxification pathways.
Coriander (Coriandrum sativum) is an herb in the family Apiaceae and is native to southern Europe and northern Africa to southwestern Asia. Although all parts of the plant are edible, its fresh leaves and dried seeds are most frequently used in cooking. Coriander is a common ingredient in many foods throughout the world. One of its principal constituents is linalool. Several animal studies provide evidence that coriander seeds can promote the hepatic antioxidant system. Feeding a 10% coriander seed diet to male Wistar rats for 12 weeks decreased the ability of hexachlorocyclo-hexane, an organochlorine insecticide, to promote lipid peroxidation (Aruna and Sivaramakrishnan 1990; Anilakumar, Nagaraj, and Santhanam 2001). Coriander can also influence foreign compound metabolism. Feeding Swiss mice with 160-mg coriander seeds per gram diet resulted in GST induction ranging from 20% to 37%, depending on the tissue examined. In another study, Banerjee et al. (1994) observed roughly a doubling in GST activity in Swiss albino mice that were provided with diets containing coriander oil (10 μL coriander oil daily for 2 weeks). No significant changes were observed in CYP or aryl hydrocarbon hydroxylase. Although relatively few studies focus on coriander for its
Cumin (Cuminum cyminum) is a flowering plant in the family Apiaceae and is native to the eastern Mediterranean region and India. Thymoquinone (TQ) is the most abundant component of black cumin seed oil. TQ has been reported to exhibit antioxidant, antimicrobial, anti-inflammatory, and chemopreventive properties (Allahghadri et al. 2010; Nader, el-Agamy, and Suddek 2010) and to ameliorate B(a)P-induced carcinogenesis in the forestomach. Swiss mice that were fed 160-mg cumin seeds per gram of diet and injected with B(a)P to induce chromosome aberrations were able to suppress the aberrations by 83% compared to controls (Aruna and Sivaramakrishnan 1990). Part of this response may be due to cumin’s ability to influence phase II enzymes. In another study by Banerjee et al., feeding Swiss mice with 10-μL cumin oil daily for 2 weeks caused a 13% increase in GST levels (p < .1). No statistically significant changes were observed in CYP activity, aryl hydrocarbon hydroxylase levels, or sulfhydryl levels in the liver compared to the control group, and thus, the first, and possibly most important, change may be an elevation in GST activity (Banerjee et al. 1994). Aruna et al. (2005) studied male albino Wistar rats to determine the effect of cumin seeds (0.25 g cumin/kg body weight) on oxidative stress induced by alcohol and heated sunflower oil, a source of polyunsaturated fatty acids. The rats’ antioxidant status was determined to be near normal when cumin was consumed with alcohol and preheated oil, potentially due to cumin’s antioxidant and detoxification properties (Aruna, Rukkumani, and Menon 2005).
Considerable evidence points to the ability of TQ to suppress tumor cell proliferation, including colorectal carcinoma, breast adenocarcinoma, osteosarcoma, ovarian carcinoma, myeloblastic leukemia, and pancreatic carcinoma (Gali-Muhtasib, Roessner, and Schneider-Stock 2006). Normal cells appear to be slightly resistant to TQ (Worthen, Ghosheh, and Crooks 1998). Several mechanisms may explain the ability of TQ to bring about a change in cell division in neoplastic cells, including downregulation in Bcl-xL, cyclin D1, and VEGF (Aggarwal et al. 2008). Considerable evidence points to the ability of TQ to induce free radical formation in tumor cells. Thus, the biological response in tumor cells (pro-oxidants) may be different than that in normal cells (antioxidant; Koka et al. 2010). TQ has also been found to be effective in inhibiting human umbilical vein EC migration, invasion, and tube formation, suggesting its role in angiogenesis (Yi et al. 2008). TQ (6 mg/kg/day) was also found to prevent tumor angiogenesis in a xenograft human prostate cancer (PC-3) model (Yi et al. 2008). The multitude of effects caused by cumin serves as justification for its continued examination as a spice with widespread potential for health promotion.
Dill (Anethum graveolens) is a relatively short-lived perennial spice. Dill is an herb that in effect has two components that are dependent on the seasons. In the early spring, dill is used for its leaves and in the autumn for its seeds. The principal constituents of dill weed oil are anethofuran or 3,6-dimethyl-2,3,3a,4,5,7a-hydroxobenzofuran, and carvone or p-mentha-1,8-dien-2-one (Zheng, Kenney, and Lam 1992). As with other spices, there is evidence that dill promotes drug detoxification mechanisms. Providing 20 mg each of carvone and anethofuran by gavage once every 2 days for a total of three doses increased GST activity in A/J mice (Zheng, Kenney, and Lam 1992). The response depended on the agent and the tissue examined. Anethofuran more than doubled the activity of the detoxifying enzyme GST in the liver (p < .005) and forestomach (p < .005), and carvone increased GST activity 78% in the forestomach (p < .05) and increased GST activity more than twofold in the liver and large intestinal mucosa (p < .05) and more than threefold in the small intestinal mucosa (p < .005; Zheng, Kenney, and Lam 1992). Because GSH helps maintain cellular oxidation-reduction balance and protects cells against free-radical species, the combination of increased GST and GSH levels results may be particularly helpful in detoxifying foreign compounds, including carcinogens.
Garlic (Allium sativum) is a member of the onion family Alliaceae. Garlic has been used throughout history for both its culinary and medicinal properties. Garlic’s distinctive characteristics arise from sulfur, which constitutes almost 1% of its dry weight. The primary sulfur-containing constituents are γ-glutamyl-S-alk(en)yl-L-cysteines and S-alk(en)yl-L-cysteine sulfoxides. Considerable variation in the S-alk(en)ylcysteine sulfoxide content can occur; alliin (S-allylcysteine sulfoxide) is the largest contributor. Alliin concentrations can increase during storage because of the transformation of γ-glutamylcysteines. Although garlic does not typically serve as a major source of essential nutrients, it may contribute to several dietary factors with potential health benefits, including the presence of oligosaccharides, arginine-rich proteins and, depending on soil and growing conditions, selenium and flavonoids.
Preclinical models provide rather compelling evidence that garlic and its associated components can lower the incidence of breast, colon, skin, uterine, esophagus, and lung cancers. However, evidence in human investigations is less compelling. Suppression of nitrosamine formation continues to surface as one of the most likely mechanisms by which garlic retards cancer. The ability of S-allyl cysteine (SAC) and its nonallyl analog S-propyl cysteine to retard N-nitroso compounds formation, but not diallyl disulfide (DADS), dipropyl disulfide, and diallyl sulfide (DAS), reveal the critical role that the cysteine residue plays in inhibition (Milner 2001). Some of the most compelling evidence in humans comes from studies by Mei et al. (1989) demonstrating that ingesting 5 g/day of garlic blocked the enhanced urinary excretion of nitrosoproline resulting from exaggerated nitrate and proline intake. More recent evidence suggests as little as 1 g of garlic may be sufficient to suppress nitroproline formation (Cope et al. 2009).
The ability of garlic to inhibit tumors due to different cancer-inducing agents and in different tissues indicates that a generalized cellular event is likely responsible for the change in tumor incidence and that the response is highly dependent on environmental or other types of biological insults. Because metabolic activation is required for many of these carcinogens, there is likelihood that either phase I or II enzymes are altered. Interestingly, little change in CYP1A1, 1A2, 2B1, or 3A4 activities has been detected following treatment with garlic or related sulfur compounds. However, this lack of responsiveness may relate to the amount and duration of exposure, the quantity of carcinogen administered, or the methods used to assess the cytochrome content or activity. Wu et al. (2002), using immunoblot assays, found that the protein content of CYP1A1, 2B1, and 3A1 was increased by garlic oil and each of several isolated disulfide compounds. Their data demonstrated that the number of sulfur atoms in the allyl compound is inversely related to the depression in these cytochromes.
Several lipid- and water-soluble organosulfur compounds have been examined for their antiproliferative efficacy. Some of the more commonly used lipid-soluble allyl sulfur compounds in tumorigenesis research are ajoene, DAS, DADS, and diallyl trisulfide (DATS). A breakdown of allicin appears to be necessary for achieving maximum tumor inhibition. Earlier studies reported that lipid-soluble DAS, DADS, and DATS (100 μM) were more effective in suppressing canine tumor cell proliferation than isomolar water-soluble SAC, S-ethyl cysteine and S-propyl cysteine (Knowles and Milner 2001). Undeniably, not all allyl sulfur compounds from garlic are equally effective in retarding tumor proliferation. Allyl sulfur compounds preferentially suppress neoplastic over non-neoplastic cells (Sakamoto, Lawson, and Milner 1997). S-allylmercaptocysteine (SAMC), DAS, and DADS have also been reported to increase the percentage of cells blocked within the G2/M phase. p34cdc2 kinase is a complex that governs the progression of cells from the G2 phase into the M phase of the cell cycle (Knowles and Milner 2001). Using LNCaP and HCT-116 human cancer cells, Xiao, Zeng, and Singh (2009) demonstrated that checkpoint kinase 1-mediated mitotic arrest resulting from DATS is the key to apoptosis induction. It is becoming increasingly clear that the response to allyl sulfurs relates to their ability to form free radicals rather than to serve as an antioxidant (Antosiewicz et al. 2008). Allyl sulfurs may bring about changes by influencing the genomic expression by affecting histone homeostasis. Allyl mercaptan is a particularly potent inhibitor of histone deacetylase (HDAC; Nian et al. 2009). HDAC inhibition has the potential to derepress epigenetically silenced genes in cancer cells, leading to cell-cycle arrest and apoptosis. Sp3 appears to have a role in driving p21 gene expression after HDAC inhibition by allyl sulfur compounds and coincides with cell-cycle arrest. Alliin has been reported to influence angiogenesis. It causes a dose-dependent inhibition of fibroblast growth factor 2 (FGF-2)-induced human EC tube formation and angiogen- esis in the chick chorioallantoic membrane model (Mousa and Mousa 2005). Xiao et al. (2006) suggested the antiangiogenic characteristics of DATS relate to its ability to downregulate VEGF secretion and VEGF receptor-2 protein level and inactivation of Akt kinase. However, while DATS was effective in decreasing prostate cancer multiplicity in the transgenic adenocarcinoma of the mouse prostate model, it did not appear to relate to a change in angiogenesis (Singh et al. 2008).
Ginger (Zingiber officinale) is a member of the Zingiberaceae family and is consumed widely not only as a spice but also as a medicinal agent (see also Chapter 7 on ginger). Other members of the family include turmeric and cardamom. Ginger’s cultivation appears to have begun in South Asia and has now spread to various parts of the world. It is sometimes called “root ginger” to distinguish it from other products that share the name. The principal constituents of ginger include -gingerol, -paradol, -shogaol (dehydration gingerols), and zingerone. Several studies have investigated ginger’s antioxidant properties (Chrubasik, Pittler, and Roufogalis 2005). Gingerol has also been shown to decrease intracellular ROS formation in human keratinocyte cells (Kim et al. 2007), inhibit angiogenesis in human ECs, and limit nitrogen oxide synthase expression and epidermal growth factor-induced cell transformation and AP-1 transcriptional complexes in JB6 cells (Bode et al. 2001; Ippoushi et al. 2003; Davies et al. 2005; Kim et al. 2005).
Feeding NIN/Wistar rats a diet containing up to 0.5-5% ginger for 1 month significantly increased (p < .05) several liver antioxidant enzymes, including superoxide dismutase (76–141%), catalase (37–94%), and GPx (11–30%; Kota, Krishna, and Polasa 2008). Lipid and protein oxidation was inhibited in rats consuming ginger, as evidenced by significant decreases (p < .05) in liver and kidney levels of MDA (35-59% and 27-59%, respectively) and carbonyl levels (23-36%), compared to controls (Kota, Krishna, and Polasa 2008). Ippoushi et al. (2007) found that AIN-76 basal diets with 2% ginger decreased TBARS by 29% (p < .05) and suppressed 8-hydroxy-2′-deoxyguanosine (8-OHdG, a product of oxidative DNA damage) levels in Wistar rats. TBARS was also significantly decreased (p < .001) in Wistar rats fed with diets supplemented with 1% ginger following exposure to lindane, a pesticide that is a global pollutant, (Ahmed et al. 2008).
Various animal models have been used to examine the role of ginger in cancer prevention. For example, Ihlaseh et al. (2006) exposed male Wistar rats to N-butyl-N-(4-hydroxybutyl)-nitrosamine (BNN) and uracil salt to induce tumors resembling human low-grade papillary urothelial neoplasia. Rats fed with a basal diet supplemented with 1% ginger extract for 26 weeks had significantly fewer urothelial lesions compared to the controls or those fed with the diet with 0.5% ginger (p = .013; Ihlaseh et al. 2006). However, ginger does not appear effective in all cases, as evidenced by the lack of protection against proliferative lesions in the bladders of Swiss mice fed with a 1% or 2% extract and exposed to BNN/N-methyl-N-nitrosourea (Bidinotto et al. 2006).
Induction of phase I and II activities may partially account for ginger’s anticarcinogenic actions. Banerjee et al. (1994) found that providing 10-μL ginger oil daily for 2 weeks to Swiss mice increased aryl hydrocarbon hydroxylase activity about 25% (p < .05) and increased GST by 60% (p < .01). No significant increase in GST induction was observed in Swiss mice fed with 160 mg ginger/gram diet (Aruna and Sivaramakrishnan 1990).
Inflammation is a significant risk factor for cancer, including prostate cancer. Mitogen-activated protein kinase phosphatase-5 (MKP5) is implicated as a proinflammatory inhibitor in innate and adaptive immune response in vivo (Zhang et al. 2004). Providing -gingerol upregulated MKP5 expression in normal prostate epithelial cells treated with 50 μM gingerol; likewise, it upregulated MKP5 expression in human prostate cancer cell lines (DU145, PC-3, LNCaP and LAPC-4; Nonn, Duong, and Peehl 2007). Ginger extracts, more so than their individual components, have been shown to inhibit lipopolysaccharide-induced prostaglandin E2 (PGE2) production to an extent similar to that of indomethacin, a nonsteroidal anti-inflammatory drug. Subfractions of ginger extract decreased LPS-induced COX-2 mRNA expression levels, although apparently not through the nuclear factor κB (NF-κβ) or activating protein 1 (AP-1) transcription factor pathways, because the ginger extracts did not inhibit TNF-α production (Lantz et al. 2007). -paradol, another active compound in ginger, is reported to induce apoptosis in human promyelocytic leukemia cells, JB6 cells, an oral squamous carcinoma cell line, and Jurkat human T-cell leukemia cells in a dosedependent manner (Huang, Ma, and Dong 1996; Lee and Surh 1998; Keum et al. 2002; Miyoshi et al. 2003). It is unclear whether -paradol has molecular targets similar to -gingerol.
Ginger also appears to have antitumorigenic properties. Several cell lines have been examined for their sensitivity to ginger. For example, alcoholic extracts of ginger inhibited tumor cell growth for Dalton’s lymphocytic ascites tumor cells and human lymphocytes at concentrations of 0.2-1 mg/mL in vitro (Unnikrishnan and Kuttan 1988). In a study of cytotoxic activities of several compounds in ginger against four tumor cell lines (A549, human lung cancer; SK-OV-3, human ovarian cancer; SK-MEL-2, human skin cancer; and HCT-15, human colon cancer), -shogaol was the most potent (ED50: 1.05–1.76 μg/mL), and -, -, -, and -gingerol displayed moderate cytotoxicity (ED50: 4.92-30.05; Kim et al. 2008). Adding -gingerol (25 μM) has been reported to inhibit proliferation in rat ascites hepatoma cells AH109A and increase apoptosis at higher concentrations (50 μM; Yagihashi, Miura, and Yagasaki 2008). Likewise, adding -shogoal (60 μM) to COLO295 cells has been reported to increase the expression of GADD153, a gene that promotes apoptosis (Chen et al. 2007). -shogaol (>50 μM) also provokes DNA damage and apoptosis through an oxidative stressmediated caspase-dependent pathway (Chen et al. 2007). Similarly, incubation of HEp-2 cells with ginger (250 μg/mL, 500 μg/mL, or 1000 μg/mL) resulted in a dose-dependent decrease in nitrite generation, increased production of superoxide, and decreased GSH levels compared to untreated cells, indicating ginger-induced apoptosis through the generation of ROS (Chen et al. 2007).
Ginger is also recognized for its potential usefulness to reduce nausea. To determine whether ginger had antiemetic effects in cisplatin-induced emesis, Manusirivithaya et al. (2004) conducted a randomized, double-blinded, crossover study in 48 gynecologic cancer patients. The addition of ginger (1 g/day) to a standard antiemetic regimen has no advantage in reducing nausea or vomiting in the acute phase of cisplatin-induced emesis. In the delayed phase, ginger and metoclopramide have no statistically significant difference in efficacy (Manusirivithaya et al. 2004). In another study, 1000 mg of ginger was compared to 20-mg intravenous (IV) metoclopramide, and to 4-mg IV ondansetron in controlling nausea in patients receiving cyclophosphamide chemotherapy. Ginger was determined to be as effective as metoclopramide, but neither was as effective as ondansetron (Sontakke, Thawani, and Naik 2003).
Overall, while the anticancer findings of ginger are intriguing and several processes may be associated with the observed responses, additional studies are needed to clarify the underlying mechanisms and to determine overall benefits to humans (Pan et al. 2008).
Rosemary (Rosmarinus officinalis) is a woody herb with fragrant needle-like leaves. Rosemary is native to the Mediterranean region and possesses a bitter, astringent taste and highly aromatic characteristics that complement a wide variety of foods. Rosemary is a member of the family Lamiaceae, and it contains a number of potentially biologically active compounds, including antioxidants such as carnosic acid and rosmarinic acid. Other bioactive compounds include camphor (up to 20% in dry rosemary leaves), caffeic acid, ursolic acid, betulinic acid, rosmaridiphenol, and rosmanol.
Due to its high antioxidant activity, crude and refined extracts of rosemary are now widely available commercially (Ho et al. 2000). While the data are difficult to interpret, when rosemary is added along with other herbs to a balsamic vinegar preparation used in soups and salads, it appears to provide protection again oxidative stress in humans (Dragan et al. 2007).
Considerable evidence also suggests that rosemary extracts, or its isolated components, can retard chemically induced cancers. For example, topical application of a rosemary extract has been reported to block the initiation and promotion phases of B(a)P- and DMBA-mediated skin tumorigenesis (Huang et al. 1994). Likewise, topical application of pure carnosol and ursolic acid also inhibited 12-0-tetradecanoylphorbol 13-acetate (TPA)-induced skin tumor promotion in DMBA-initiated mice (Huang et al. 1994). Adding rosemary or carnosol has also been shown to retard DMBA-induced mammary cancer in rats (Singletary, MacDonald, and Wallig 1996). The depression in tumors may occur because of a change in the types and amounts of DMBA adducts bound to DNA (Amagase et al. 1996). Although not extensively studied, such evidence suggests the ability of rosemary to influence drug-metabolizing enzymes.
Rosemary extracts and the active compounds carnosic acid and rosmarinic acid have been found to inhibit the proliferation of various human cancer cell lines, including NCI-H82 (human, small cell lung carcinoma), DU145 (human prostate carcinoma), Hep-3B (human [black] liver carcinoma), K-562 (human chronic myeloid leukemia), MCF-7 (human breast adenocarcinoma), PC-3 (human prostate adenocarcinoma), and MDA-MB-231 (human breast adenocarcinoma; Yesil-Celiktas et al. 2010). Part of the antitumorigenic properties associated with rosemary may relate to a decrease in TNF-α-induced ROS generation and NF-κB activation, and thus enhanced TNF-α-induced apoptosis (Moon et al. 2010). Carnosol was the most effective in reducing tumor proliferation. Carnosol is also known to induce apoptotic cell death in high-risk pre-B acute lymphoblastic leukemia (ALL; Dorrie, Sapala, and Zunino 2001). At least part of this response may relate to a decrease in Bcl-2. Although carnosol may be effective, it may also interfere with the actions of some other antitumor agents. Zunino and Storms (2009) reported that carnosol decreased the percentage of cell death in the pre-B ALL lines SEM, RS4;11, and REH when combined with cytarabine, methotrexate, or vincristine compared to these chemotherapeutic agents alone. Overall, these data suggest that carnosol, and possibly other constituents in rosemary, may block the terminal apoptotic events induced by some chemotherapeutic drugs and therefore may decrease the effectiveness of some standard therapies for leukemia.
Saffron is a spice derived from the flower of the saffron crocus (Crocus sativus) plant native to Southwest Asia. It has historically been the world’s most expensive spice per unit weight. Saffron imparts a bitter taste and hay-like fragrance to food. Saffron likely contains more than 150 volatile and aroma-yielding compounds. A carotenoid, α-crocin, comprises >10% of dry saffron’s mass and is responsible for the rich golden-yellow hue created when saffron is added to food dishes. Picrocrocin, a bitter glucoside, is responsible for saffron’s flavor.
Significant information points to the ability of saffron to inhibit cancer (Abdullaev 2003). Aqueous saffron preparations have been reported to inhibit chemically induced skin carcinogenesis (Das, Chakrabarty, and Das 2004). Both changes in carcinogen bioactivation and tumor proliferation appear to occur. Saffron infusion given orally either before or after DMBA treatment increased GST, GPx, catalase, and superoxide dismutase in liver (Das, Das, and Saha 2010).
Saffron and crocus also have significant antitumorigenic properties. Similar to other spices, they appear to suppress cell growth in neoplastic cells to a greater extent than in normal cells (Aung et al. 2007). The ability of crocin to decrease cell viability occurs in a concentration- and time-dependent manner (Bakshi et al. 2009). The response is not limited to cells in culture because pancreatic xenografts are also influenced by saffron (4 mg/kg diet for 30 days; Dhar et al. 2009). The effects of tumor suppression also have an impact on the longevity of the host. A significant increase in the life span of Dalton’s lymphoma-bearing animals was found in those provided with saffron (Bakshi et al. 2009).
The mechanism by which saffron suppresses tumor proliferation has not been adequately explored, but a shift in caspases and an increase in Bax protein are possible (Mousavi et al. 2009). When a saffron extract (200-2000 μg/mL) was added to MCF-7 cells in culture, there was a marked decrease in cell viability as concentration and duration of exposure increased (IC50 of 400 ± 18.5 μg/mL after 48 hours). Analysis of DNA fragmentation by flow cytometry revealed apoptotic cell death in these cells (Mousavi et al. 2009). Saffron-induced apoptosis was inhibited by pan-caspase inhibitors, indicating the importance of this process in determining the response.
Thyme is another culinary and medicinal herb. Today, common usage refers to any or all members of the plant genus Thymus, also of the Lamiaceae family. Several active agents are reported, including thymol, carvacrol, apigenin, luteolin, tannins, γ-terpinene, and other oils (Aydin, Basaran, and Basaran 2005; Kluth et al. 2007).
Feeding thyme leaves (0.5% or 2.0%) or its phenolic compounds, thymol and carvacrol (50–200 mg/kg), has been reported to enhance xenobiotic-metabolizing enzymes, including phase I enzymes such as 7-ethoxycoumarin O-deethylase and phase II enzymes such as GST and quinone reductase (Sasaki et al. 2005). Admittedly, the isolated components were more effective than feeding the leaf. Kluth et al. (2007) examined the effects of thyme on enzyme induction in cultured human liver carcinoma cells and human colon adenocarcinoma cells. They observed a thyme extract to activate CYP3A4 promoter via PXR and the GI-GPx promoter via the electrophile responsive element, thus providing potential clues about the mechanism by which thymol and carvacrol may influence phase I and II enzyme expression (Kluth et al. 2007). The number of studies on genotoxic effects of thymol and carvacrol are limited, but contradictory. S. typhimurium tests have provided some, but not compelling, evidence that thyme is weakly mutagenic (Stammati et al. 1999). In vivo, 0.25% thyme had no detectable effect on mouse embryo development (Domaracky et al. 2007). In comet assays with human lymphocytes, thymol and carvacrol did not induce DNA strand breakage at concentrations lower than 50-100 μM, and were therefore considered safe for consumers (Undeger et al. 2009).
Mounting evidence suggests that cancers are not an inevitable consequence of aging but are preventable diseases. The evidence in this chapter suggests that spices may be factors in one’s diet that may lower cancer risk and affect tumor behavior. Spices have been consumed for centuries for a variety of purposes, such as flavoring agents, colorants, and preservatives. This chapter only scratches the surface of the overall impact of herbs and spices since there are approximately 180 spices commonly being used for culinary purposes. Without question, evidence exists that multiple processes, including proliferation, apoptosis, angiogenesis, and immunocompetence, can be influenced by one or more spices. While the currently available data are intriguing, considerably more information is needed to determine who will benefit most from exaggerated intake of one or more spices, the effective exposures needed to bring about the desired outcome(s), and what interactions (both positive and negative) exist with other components of the diet or with medications that an individual may regularly consume.
Abdullaev F. Crocus sativus against cancer. Arch Med Res. 2003;34:354. [PubMed]
Aggarwal B.B. Targeting inflammation-induced obesity and metabolic diseases by curcumin and other neutraceuticals. Annu Rev Nutr. 2010;30:173–199. Epub, Apr 26. [PMC free article] [PubMed]
Aggarwal B.B, Kunnumakkara A.B, Harikumar K.B, Tharakan S.T, Sung B, Anand P. Potential of spice-derived phytochemicals for cancer prevention. Planta Med. 2008;74:1560–9. [PubMed]
Ahmed R.S, Suke S.G, Seth V, Chakraborti A, Tripathi A.K, Banerjee B.D. Protective effects of dietary ginger (Zingiber officinales Rosc.) on lindane-induced oxidative stress in rats. Phytother Res. 2008;22:902–6. [PubMed]
Al-Rehaily A.J, Al-Said M.S, Al-Yahya M.A, Mossa J.A, Rafatullah S. Ethnopharmacological studies on Allspice (Pimenta dioica) in laboratory animals. Pharm Biol. 2002;40:200–5.
Allahghadri T, Rasooli I, Owlia P, Nadooshan M.J, Ghazanfari T, Taghizadeh M, Astaneh S.D. 2010. Antimicrobial property, antioxidant capacity, and cytotoxicity of essential oil from cumin produced in Iran J Food Sci 75 2:H54-61. [PubMed]
Amagase H, Sakamoto K, Segal E.R, Milner J.A. Dietary rosemary suppresses 7,12-dimethylbenz(a)anthracene binding to rat mammary cell DNA. J Nutr. 1996;126:1475–80. [PubMed]
Anilakumar K.R, Nagaraj N.S, Santhanam K. Effect of coriander seeds on hexachlorocyclo- hexane induced lipid peroxidation in rat liver. Nutr Res. 2001;21:1455–62.
Antosiewicz J, Ziolkowski W, Kar S, Powolny A.A, Singh S.V. Role of reactive oxygen intermediates in cellular responses to dietary cancer chemopreventive agents. Planta Med. 2008;74:1570–9. [PMC free article] [PubMed]
Aruna K, Rukkumani R, Menon V.P. Role of Cuminum cyminum on ethanol and preheated sunflower oil induced lipid peroxidation. J Herbs Spices Med Plants. 2005;11:103–14.
Aruna K, Sivaramakrishnan V.M. Plant products as protective agents against cancer. Indian J Exp Biol. 1990;28:1008–11. [PubMed]
Aung H.H, Wang C.Z, Ni M, editors. Crocin from Crocus sativus possesses significant anti-proliferation effects on human colorectal cancer cells. Exp Oncol. 2007;29:175–80. [PMC free article] [PubMed]
Aydin S, Basaran A.A, Basaran N. The effects of thyme volatiles on the induction of DNA damage by the heterocyclic amine IQ and mitomycin C. Mutat Res. 2005;581:43–53. [PubMed]
Bakshi H.A, Sam S, Feroz A, Ravesh Z, Shah G.A, Sharma M. Crocin from Kashmiri saffron (Crocus sativus) induces in vitro and in vivo xenograft growth inhibition of Dalton's lymphoma (DLA) in mice. Asian Pac J Cancer Prev. 2009;10:887–90. [PubMed]
Banerjee S, Sharma R, Kale R.K, Rao A.R. Influence of certain essential oils on carcinogen- metabolizing enzymes and acid-soluble sulfhydryls in mouse liver. Nutr Cancer. 1994;21:263–9. [PubMed]
Bar-Sela G, Epelbaum R, Schaffer M. Curcumin as an anti-cancer agent: Review of the gap between basic and clinical applications. Curr Med Chem. 2010;17:190–7. [PubMed]
Bhattacharjee S, Rana T, Sengupta A. Inhibition of lipid peroxidation and enhancement of GST activity by cardamom and cinnamon during chemically induced colon carcinogenesis in Swiss albino mice. Asian Pac J Cancer Prev. 2007;8:578–82. [PubMed]
Bidinotto L.T, Spinardi-Barbisan A.L, Rocha N.S, Salvadori D.M, Barbisan L.F. Effects of ginger (Zingiber officinale Roscoe) on DNA damage and development of urothelial tumors in a mouse bladder carcinogenesis model. Environ Mol Mutagen. 2006;47:624–30. [PubMed]
Billing J, Sherman P.W. Antimicrobial functions of spices: Why some like it hot. Q Rev Biol. 1998;73:3–49. [PubMed]
Bode A.M, Ma W.Y, Surh Y.J, Dong Z. Inhibition of epidermal growth factor-induced cell trans-formation and activator protein 1 activation by -gingerol. Cancer Res. 2001;61:850–3. [PubMed]
Buzzanell P.J, Gray F. The spice market in the united states: Recent developments and prospects. USDA Agriculture Information Bulletin 1995. 709.
Cao G, Prior R.L. Comparison of different analytical methods for assessing total antioxidant capacity of human serum. Clin Chem. 1998;44:1309–15. [PubMed]
Cao H, Urban J.F Jr., Anderson R.A. Cinnamon polyphenol extract affects immune responses by regulating anti- and proinflammatory and glucose transporter gene expression in mouse macrophages. J Nutr. 2008;138:833–40. [PubMed]
Chen C.-Y, Liu T.-Z, Liu Y.-W, editors. 6-shogaol (alkanone from ginger) induces apoptotic cell death of human hepatoma p53 mutant Mahlavu subline via an oxidative stress-mediated caspase-dependent mechanism. J Agric Food Chem. 2007;55:948–54. [PubMed]
Chiang L.C, Ng L.T, Cheng P.W, Chiang W, Lin C.C. Antiviral activities of extracts and selected pure constituents of Ocimum basilicum. Clin Exp Pharmacol Physiol. 2005;32:811–6. [PubMed]
Chrubasik S, Pittler M.H, Roufogalis B.D. Zingiberis rhizoma: A comprehensive review on the ginger effect and efficacy profiles. Phytomedicine. 2005;12:684–701. [PubMed]
Cope K, Seifried H, Seifried R, Milner J, Kris-Etherton P, Harrison E.H. A gas chromatography- mass spectrometry method for the quantitation of N-nitrosoproline and N-acetyl-S-allylcysteine in human urine: Application to a study of the effects of garlic consumption on nitrosation. Anal Biochem. 2009;394:243–8. [PMC free article] [PubMed]
Das I, Chakrabarty R.N, Das S. Saffron can prevent chemically induced skin carcinogenesis in Swiss albino mice. Asian Pac J Cancer Prev. 2004;5:70–6. [PubMed]
Das I, Das S, Saha T. Saffron suppresses oxidative stress in DMBA-induced skin carcinoma: A histopathological study. Acta Histochem. 2010;112:317–27. [PubMed]
Dasgupta T, Rao A.R, Yadava P.K. Chemomodulatory efficacy of basil leaf (Ocimum basilicum) on drug metabolizing and antioxidant enzymes, and on carcinogen-induced skin and forestomach papillomagenesis. Phytomedicine. 2004;11:139–51. [PubMed]
Davies M, Robinson M, Smith E, Huntley S, Prime S, Paterson I. Induction of an epithelial to mesenchymal transition in human immortal and malignant keratinocytes by TGF-beta1 involves MAPK, Smad and AP-1 signalling pathways. J Cell Biochem. 2005;95:918–31. [PubMed]
Deeptha K, Kamaleeswari M, Sengottuvelan M, Nalini N. Dose dependent inhibitory effect of dietary caraway on 1,2-dimethylhydrazine induced colonic aberrant crypt foci and bacterial enzyme activity in rats. Invest New Drugs. 2006;24:479–88. [PubMed]
Dhar A, Mehta S, Dhar G, editors. Crocetin inhibits pancreatic cancer cell proliferation and tumor progression in a xenograft mouse model. Mol Cancer Ther. 2009;8:315–23. [PubMed]
Dhuley J.N. Anti-oxidant effects of cinnamon (Cinnamomum verum) bark and greater cardamom (Amomum subulatum) seeds in rats fed high fat diet. Indian J Exp Biol. 1999;37:238–42. [PubMed]
Dinarello C.A. Anti-inflammatory agents: Present and future. Cell. 2010;140:935–50. [PMC free article] [PubMed]
Domaracky M, Rehak P, Juhas S, Koppel J. Effects of selected plant essential oils on the growth and development of mouse preimplantation embryos in vivo. Physiol Res. 2007;56:97–104. [PubMed]
Dorrie J, Sapala K, Zunino S.J. Carnosol-induced apoptosis and downregulation of Bcl-2 in B-lineage leukemia cells. Cancer Lett. 2001;170:33–9. [PubMed]
Dragan S, Nicola T, Ilina R, Ursoniu S, Kimar A, Nimade S. Role of multi-component functional foods in the complex treatment of patients with advanced breast cancer. Rev Med Chir Soc Med Nat Iasi. 2007;111:877–84. [PubMed]
Dragland S, Senoo H, Wake K, Holte K, Blomhoff R. Several culinary and medicinal herbs are important sources of dietary antioxidants. J Nutr. 2003;133:1286–90. [PubMed]
Epstein J, Sanderson I.R, Macdonald T.T. Curcumin as a therapeutic agent: The evidence from in vitro, animal and human studies. Br J Nutr. 2010;103:1545–57. [PubMed]
Esiyok D, Otles S, Akcicek E. Herbs as a food source in Turkey. Asian Pac J Cancer Prev. 2004;5:334–9. [PubMed]
Eslick G. Helicobacter pylori infection causes gastric cancer? A review of the epidemiological, meta- analytic and experimental evidence. World J Gastroenterol. 2006;12:2991–9. [PMC free article] [PubMed]
Farinha P, Gascoyne R.D. Helicobacter pylori and MALT lymphoma. Gastroenterology. 2005;128:1579–605.. [PubMed]
Food and Drug Administration 2007. Chapter 5: Foods, Colors and Cosmetics Sub-Chapter 525: Condiment Industry. Compliance Policy Guide http://www.fda.gov/ICECI/ComplianceManuals/CompliancePolicyGuidanceManual/ucm119194.htm; 1980 .
Fung J, Lai C.L, Yuen M.F. Hepatitis B and C virus-related carcinogenesis. Clin Microbiol Infect. 2009;15:964–70. [PubMed]
Gali-Muhtasib H, Roessner A, Schneider-Stock R. Thymoquinone: A promising anti-cancer drug from natural sources. Int J Biochem Cell Biol. 2006;38:1249–53. [PubMed]
Han E.H, Hwang Y.P, Jeong T.C, Lee S.S, Shin J.G, Jeong H.G. Eugenol inhibits 7,12- dimethylbenz[a]anthracene-induced genotoxicity in MCF-7 cells: Bifunctional effects on CYP1 and NAD(P)H:quinone oxidoreductase. FEBS Lett. 2007;581:749–56. [PubMed]
Ho C.T, Wang M, Wei G.J, Huang T.C, Huang M.Y. Chemistry and antioxidative factors in rosemary and sage. Biofactors. 2000;13:161–6. [PubMed]
Huang M.T, Ho C.T, Wang Z.Y, editors. Inhibition of skin tumorigenesis by rosemary and its constituents carnosol and ursolic acid. Cancer Res. 1994;54:701–8. [PubMed]
Huang C, Ma W.Y, Dong Z. Requirement for phosphatidylinositol 3-kinase in epidermal growth factor-induced AP-1 transactivation and transformation in JB6 P+ cells. Mol Cell Biol. 1996;16:6427–35. [PMC free article] [PubMed]
Ihlaseh S.M, de Oliveira M.L, Teran E, de Camargo J.L, Barbisan L.F. Chemopreventive property of dietary ginger in rat urinary bladder chemical carcinogenesis. World J Urol. 2006;24:591–6. [PubMed]
Ippoushi K, Azuma K, Ito H, Horie H, Higashio H. -gingerol inhibits nitric oxide synthesis in activated J774.1 mouse macrophages and prevents peroxynitrite-induced oxidation and nitration reac-tions. Life Sci. 2003;73:3427–37. [PubMed]
Ippoushi K, Takeuchi A, Ito H, Horie H, Azuma K. Antioxidative effects of daikon sprout (Raphanus sativus L.) and ginger (Zingiber officinale Roscoe) in rats. Food Chem. 2007;102:237–42.
Ishikawa T. Clinical features of hepatitis B virus-related hepatocellular carcinoma. World J Gastroenterol. 2010;16:2463–7. [PMC free article] [PubMed]
Iyer A, Panchal S, Poudyal H, Brown L. Potential health benefits of Indian spices in the symptoms of the metabolic syndrome: A review. Indian J Biochem Biophys. 2009;46:467–81. [PubMed]
Jeurissen S.M, Punt A, Delatour T, Rietjens I.M. Basil extract inhibits the sulfotransferase mediated formation of DNA adducts of the procarcinogen 1'-hydroxyestragole by rat and human liver S9 homogenates and in HepG2 human hepatoma cells. Food Chem Toxicol. 2008;46:2296–302. [PubMed]
Kaefer C.M, Milner J.A. The role of herbs and spicesin cancer prevention. J Nutr Biochem. 2008;19:347–61. [PMC free article] [PubMed]
Kapoor I.P, Singh B, Singh G, De Heluani C.S, De Lampasona M.P, Catalan C.A. Chemistry and antioxidant activity of essential oil and oleoresins of black caraway (Carum bulbocastanum) fruits. J Sci Food Agric. 2010;90:385–90. [PubMed]
Kennedy E. Nutrition policy in the U.S.: 50 years in review. Asia Pac J Clin Nutr. 2008;17 1:340–2. [PubMed]
Keum Y.S, Kim J, Lee K.H, editors. Induction of apoptosis and caspase-3 activation by chemopreventive -paradol and structurally related compounds in KB cells. Cancer Lett. 2002;177:41–7. [